Box | Folder		Title
		Research Data PET Scans, 1953-2002, undated [subseries]:
		Numbered, 1981, undated [subseries]:
50	1	1 autoradiograph with standard [photographs, negative], undated
50	2	2 DG + DG2 + MG molecules [photographs, negative], undated
50	3	3 DG through brain barrier [photographs, negative], undated
50	4	4 functional anatomy of operational -- *DG equ. [photographs, negative], undated
50	5	5 lumped constant in several species [photographs, negative], undated
50	6	6 glucose utilization in conscious rat and monkey [photographs, negative], undated
50	7	7 effects of thiopental anesthesia on cerebral glucose utilization [photographs, negative], undated
50	8	8 spinal cord effects of unilateral stimulation [photographs, negative], undated
50	9	9 relationship between frequency of stimulation and LGU [photographs, negatives, slides], undated
50	10	10 focal seizure during LGU [photographs, negatives], undated
50	11	11 otitis [photographs, negatives], undated
50	12	12 left eye removed (rat) L.G.U. [photographs, negatives], undated
50	13	13 coronal brain (monkey) [photographs, negatives], undated
50	14	14 coronal brain (monkey) -- rt. eye occluded, undated
50	15	15 [negative], undated
50	16	16 12 hr. lt./12 hr. dk. (glucose utilization) [photographs, negative], undated
50	17	17 apomorphine rt. eye enucleated [photographs, negative], undated
50	18	18 effects of d- and 1- amphetamine on LCGU in rat [photographs, negative], undated
50	19	19 computer diagram image display system [photographs, negative], undated
50	20	20 average brain cerebral glucose utilization [negative], undated
50	21	21 ageing and metabolism [photographs, negative], undated
50	22	22 ageing and metabolism [photographs, negative], undated
50	23	23 ageing and metabolism, LCGU vs. apomorphine [photographs, negative], undated
50	24	24 ageing, LCGU vs. apomorphine [photographs, negative], undated
50	25	25 LCGU vs. aopmorphine (subthalamic nucleus and inferior olivary nucleus) [photographs, negative], undated
50	26	26 LCGU vs. apomorphine (ageing) [photographs, negative], undated
50	27	27 DG, FDG, CH3 -- glucose, brain pictures [photographs, negative], undated
50	28	28 glucose metabolic rate (FDG) [photographs, negative], undated
50	29	29 LCGU vs. apomorphine (age), undated
50	30	30 LCBF w/[I125] Hipdm vs. [C14} idoantipyrine [photographs, negative], undated
50	31	31 LCBF indicator fraction method [photographs, negative], undated
50	32	32 spreading depression [photographs, negative], undated
50	33	33 [photographs, negative], undated
50	34	34 electrical stimulation and DG* uptake in pituitary [negative], undated
50	35	35 socium pump and neurosecretion effects on DG* uptake [photographs, negative], undated
50	36	36 [125] hipdm and products vs. radioactivity in arterial blood [photographs, negative], undated
50	37	37 radioactivity DPM vs. time curves [photographs, negative], undated
50	38	38 spreading cortical depression (KCI) [photographs, negative], 1981
50	39	39 osmotic opening of BBB [photographs, negative], undated
50	40	40 blood flow vs. LGU in conscious and anesthetized [photographs, negative], undated
50	41	41 [photographs, negative], undated
50	42	42 glucose utilization in dark-adapted rats (saline vs. apomorphine) [photographs, negative], undated
50	43	43 dark-adapted rats (eye enucleated) saline vs. apomorphine [photographs, negative], undated
50	44	44 effects of light intensity on LGU [photographs, negative], undated
50	45	45 [125I] hipdm single pass extraction vs. venous [photographs, negative], undated
50	46	46 deosyglucose vs. glucose in arterial and venous [photographs, negative], undated
50	47-48	47 influence of rate constants on integrated pool specific activity [photographs, negative], undated
50	49	48 rate constants in the normal conscious albino rat [negative], undated
50	50	49 lump constant vs. time [photographs, negative], undated
50	51	50 cerebral metabolism of [14C] DG and G in vivo [photographs, negative], undated
50	52	51 blood CO2 curves [photographs, negative], undated
50	53	52 striate cortex (monkey) [photographs, negative], undated
50	54	53 autoradiograph dorsolateral surface of monkey occipital lobe [photographs, negative], undated
50	55	54 LCGU vs. apomorphine [photograph, negative, slides], undated
50	56	55 systems involved in higher functions [negative], undated
50	57	56 auditory system (LCGU) [negative], undated
50	58	57 auxtomy, leucine protein synthesis [photographs, negative], undated
50	59	58 auxtomy, DG, protein synthesis nissl stain [photographs, negative], undated
50	60	59 3H and 24C DG [photographs, negative], undated
50	61	60 brain anatomy labeled [photographs, negative], undated
50	62	61 experimental period effects on gray matter glucose utilization [photographs, negative], undated
50	63	62 visual stimulus (3H] DG [photographs, negative], undated
50	64	63 pretectal nucleus [photographs, negative], undated
50	65	64 visual cortex [photographs, negative], undated
50	66	65 lateral geniculate nucleus [photographs, negative], undated
50	67	66 posterolateral nucleus of the thalamus [photographs, negative], undated
50	68	67 blood flow vs. LCGU (control) [photographs, negative], undated
50	69	68 blood flow vs. LCGU (acidosis) [photographs, negative], undated
50	70	69 blood flow vs. LCGU (acidosis and control) [photographs, negative], undated
50	71	70 antidromic stimulation of superior cervical ganglion [photographs, negative], undated
50	72	71 superior colliculus LCGU vs. light intensity [photographs, negative], undated
50	73	72 *DG and *DG-6-phosphate concentration over time [photographs, negative], undated
50	74	73 antidomic stimulation of superior cervical ganglion [photographs, negative], undated
50	75	74 antidromic stimulation of superior cervical ganglion [photographs, negative], undated
50	76	75 air embolism and control in K+ concentration [photographs, negative], undated
50	77	76 air embolism and control in pH of injection fluid [photographs, negative], undated
50	78	78 post axotomy and control [photographs, negative], undated
50	79	80 [photographs, negative], undated
50	80	81 hypoxemia [photographs, negative], undated
50	81	82 darkness vs. 700 lux (pigmented rats) [photographs, negative], undated
50	82	83 hypoxemia [photographs, negative], undated
50	83	84 hypoxemia [photographs, negative], undated
50	84	85 darkness vs. 700 lux (albino rats) [photographs, negative], undated
50	85	86 newborn monkey [photographs, negative], undated
50	86	87 [photographs, negative], undated
50	87	88 spinal cord [photographs, negative], undated
50	88	89 globus pallidus, etc. [negative], undated
50	89	90 reginal glucose utilization [photographs, negative], undated
50	90	91 reginal glucose metabolism after 10 min. cerebral ischemia in the rat [photographs, negative], undated
50	91	92 [photograph], undated
50	92	93 left eye removed [photographs, negative], undated
50	93	94 penn. seizure antipyrine, baby monkey [photographs, negative], undated
50	94	95 effects of thiopental anesthesia on cerebral glucose utilization [photograph], undated
50	95	97 equilibration of glucose specific activity between plasma and brain [photographs, negative], undated
50	96	98 influence of duration on glucose utilization [photographs, negative], undated
50	97	99 relationship between stimulation and L.G.U. [photographs, negative], undated
50	98	100 determination of glucose specific activity [photographs, negative], undated
50	99	101 brain-plasma glucose equilibration, undated
50	100	102 tissue glucose pool 1/2 life vs. plasma glucose concentration [photographs, negative], undated
50	101	103 glucose activity in plasma, tissue [negative], undated
50	102	104 cerebral 02 consumption in cerebral blood flow [photographs, negative], undated
50	103	105 half-lives of DG*-6-P in grey and white matter [photographs, negative], undated
50	104	106 arterial and venous [ ] of 14c D.G. following i.v. in a cat [photographs, negative], undated
50	105	107 derivation of operational method for measurement of LCGU [photographs, negative], undated
50	106	108 tissue pool 1/2 life [photographs, negative], undated
50	107	109 math. analysis of model for total accumulation of DG* and DG*-P [photograph, negative], undated
50	108	110 theoretical calculation of [14c] DG-6-P in rat brain [photographs], undated
50	109	111 general equation + influence of phosphotase activity [photograph, negative], undated
50	110	112 lumped constant calculation used by Hawkins and Miller [photographs], undated
50	111	113 [photograph], undated
50	112	114 equation for changing plasma glucose concentration [photograph, negative], undated
50	113	115 BBB model and equation of 14C glucose uptake [photograph, negative], undated
50	114	116 glucose uptake model + equation [photographs, negative], undated
50	115	117 LCGU in conscious albino and pigmented rats [negative], undated
50	116	118 glucose utilization in sensorimotor systems [negative], undated
50	117	119 glucose utilization in myelinated fiber tracts [negative], undated
50	118	120 glucose utilization in limbic system [negative], undated
50	119	121 glucose utilization in conscious and restrained rats [negative], undated
50	120	122 glucose utilization of the visual system [negative], undated
50	121	123 1/2 life of tissue pool in male rats [negative], undated
50	122	124 turnover of tissue glucose pool in male rats [negative], undated
50	123	125 values of rate constants in normal conscious albino rats [photographs, negative], undated
50	124	127 conditions w/altered function in CNS w/out change in average body metabolism [photograph], undated
50	125	128 relationship between consciousness and cerebral metabolic rate [photograph], undated
50	126	129 sodium pump and neurosecretion effects on DG* uptake, undated
50	127	130 functional anatomy of the DG*method equ. [photographs, negative, slide], undated
50	128	131 operational equation of [14C] DG method [photographs, negatives], undated
50	129	132 plasm -- tissue B-B-B (revised by Smith) [photographs, negatives], undated
50	130	135 LCBF with hipdm indicator fractionation method [photographs, negatives], undated
50	131	136 [14c] glucose-6-P single pass extraction fraction [photographs, negatives], undated
50	132	137 LCBF w/[I125] hipdm tissue equilibration method [photographs, negatives], undated
50	133	138 retinal stimulation in rats [photographs, negatives], undated
50	134	139 local cerebral glucose utilization [photographs, negatives], undated
50	135	140 local cerebral blood flow [photographs, negatives], undated
50	136	141 kinetics of competitive substrate reactions [photographs, negatives], undated
50	137	142 CBF and CMR 02 vs. years [photographs, negatives], undated
50	138	143 influence of CO2 in correlation between LCBF and LCGU [photographs, negatives], undated
50	139	144 monkey [photographs, negatives], undated
50	140	145 glucose utilization vs. stimulation frequency [photographs, negatives], undated
50	141	146 operational equation of [14C] deoxyglucose method [photograph], undated
50	142	147 cervical ganglion drawing [photographs, negatives], undated
51	1	148 cervical ganglion drawing [photographs, negatives], undated
51	2	149 cervical ganglion (micro) [photographs, negatives], undated
51	3	150 effects of apomorphine upon glucose utilization in habenula [photographs, negatives], undated
51	4	151 LCGU vs. halperidol [photographs, negatives], undated
51	5	152 LCGU vs. apomorphine [photographs, negatives], undated
51	6	153 preanglionic holinergic fibers [photographs, negatives], undated
51	7	154 pre-ganglionic cholinergic [photographs, negatives], undated
51	8	155 focal seizures -- protein synthesis [photographs, negatives], undated
51	9	156 focal seizures (metabolic effects) [photographs, negatives], undated
51	10	157 optical density, apomorphine vs. halperidol [photographs, negatives], undated
51	11	158 apomorphine vs. haloperidol (magnification) [photographs, negatives], undated
51	12	159 slide to side differences in monkey brain structures [photographs, negatives], undated
51	13	160 LGU in monkey brain [photographs, negatives], undated
51	14	161 influence of age on responsiveness to apomorphine [photographs, negatives], undated
51	15	162 influence of age on responsiveness to apomorphine (zona compacta) [photographs, negatives], undated
51	16	163 influence of age on responsiveness to apomorphine (aged 48-67) [photographs, negatives], undated
51	17	164 cervical ganglion [photographs, negatives], undated
51	18	165 regional glucose utilization [photographs, negatives], undated
51	19	166 regional glucose utilization (ketamine) [photographs, negatives], undated
51	20	167 regional glucose utilization (limbic system) [photographs, negatives], undated
51	21	168 regional glucose utilization: auditory, visual, sensory [photographs, negatives], undated
51	22	169 physiologic pearmeters [photographs, negatives], undated
51	23	170 LCGU (percentage change from control) [photographs, negatives], undated
51	24	171 LCGU (percentage change from control) ketamine [photographs, negatives], undated
51	25	172 blood flow transport and metabolism [photographs, negatives], undated
51	26	173 SSA vs. 1/[GHB] [photographs, negatives], undated
51	27	174 SSA or NADPH vs. 1/[NADP+] [photographs, negatives], undated
51	28	175 SSA or NADPH vs. time [photographs, negatives], undated
51	29	176 1/[GHB] vs NADPH, NADPH vs. 1/[NADPH] [photographs, negatives], undated
51	30	177 NADPH vs. 1/[NADPH] and 1/[GHD] [photographs, negatives], undated
51	31	178 SA vs. [GHB] and [D-glucuronate] [photographs, negatives], undated
51	32	179 apomorphine substantia nigra young vs. aged rats [photographs, negatives], undated
51	33	180 monocular deprivation (neonatal monkey) [photographs, negatives], undated
51	34	181 naftidro furyl [photographs, negatives], undated
51	35	182 hypoxemia metabolic raes [photographs, negatives], undated
51	36	183 lateral genic (monkey) [photographs, negatives], undated
51	37	184 ketamine [photographs, negatives], undated
51	38	185 norepinephrine vs. LCGU [photographs, negatives], undated
51	39	186 norepinephrine vs. control LCGU [photographs, negatives], undated
51	40	187 LCGU in white matter during hypoxemia [photographs, negatives], undated
51	41	188 awake/asleep, striate cortex and sensory-motor cortex [photographs, negatives], undated
51	42	189 lumped constant vs. plasma glucose [photographs, negatives], undated
51	43	190 superior cervical ganglia/glucose utilization [photographs, negatives], undated
51	44	191 coeliac and cardiac ganglia/glucose utilization [photographs, negatives], undated
51	45	192 hexokinase synthesis chart [photographs, negatives], undated
51	46	193 physiological variables in hypoxemia [photographs, negatives], undated
51	47	194 average rate of G.U. in whole brain during hypoxemia [photographs, negatives], undated
51	48	195 captopril effects on G. U. of subfornical organ in Brattleboro rats [photographs, negatives], undated
51	49	196 deoxyglucose autoradiographs of cat lumbar spinal cord [photographs, negatives], undated
51	50	197 lumbar spinal cord + brain autoradiographs and stained [photographs, negatives], undated
51	51	198 hyperglycemia lumped constant [photographs, negatives], undated
51	52	199 time course of arterial and venous concentrations of DG* and G [photographs, negatives], undated
51	53	200 model for behavior of leucine in brain [photographs, negatives], undated
51	54	201 glucose clamp [photographs, negatives], undated
51	55	202 lumped constant at different plasma glucose levels, undated
51	56	203 conversion of leucine to acetoacetic acid and acetyl-coenzyme A [photographs, negatives], undated
51	57	204 metabolic rates during hypoxemia [photographs, negatives], undated
51	58	205 axotomy hypoglossal nucleus [photographs, negatives], undated
51	59	206 derivation of operational equ.-model I [photographs, negatives], undated
51	60	207 behavior of leucine in brain model [photographs, negatives], undated
51	61	208 differential equations leucine [photographs, negatives], undated
51	62	209 behavior of leucine in brain model 2 [photographs, negatives], undated
51	63	210 differential equations leucine II [photographs, negatives], undated
51	64	211 derivation of operational equ. -- model III [photographs, negatives], undated
51	65	212 leucine brain -- model III [photographs, negatives], undated
51	66	213 differential equations model III [photographs, negatives], undated
51	67	214 derivation of operational equ. model III [photographs, negatives], undated
51	68	215 derivation of operational equ. III continued [photographs, negatives], undated
51	69	216 derivation of equation [photographs, negatives], undated
51	70	217 model IV -- amino acid incorporation into protein [photographs, negatives], undated
51	71	218 derivation of operational equ. model IV [photographs, negatives], undated
51	72	219 derivation of operational equ. -- model IV continued [photographs, negatives], undated
51	73	220 lumped constant in hypoglycemia [photographs, negatives], undated
51	74	221 DG model -- intracellular and extracellular spaces [photographs, negatives], undated
51	75	222 LCGU kates of insulin-induced hypoglycemia rats [photographs, negatives], undated
51	76	224 physiological variables during insulin-induced hypoglycemia [photographs, negatives], undated
51	77	225 determination of the 1/2 life of the precursor leucine pool [photographs, negatives], undated
51	78	226 synthesis and catabolism of histamine, undated
51	79	227 determination of activity of L-leucine and TRNA-bound leucine [photographs, negatives], undated
51	80	228 scheme for oxidation of [ ]-yydroxybutyrate/ reduction of D-glucuranate [photographs, negative], undated
51	81	229 superior cervical ganglia (G.U. vs. time) [photographs, negative], undated
51	82	230 synaptic mechanisms for histamine neurons [photographs, negative], undated
51	83	231 visual cortex of monkey [photographs], undated
51	84	232 fetal sheep [photographs, negative], undated
51	85	233 fetal sheep? [photographs, negative], undated
51	86	234 saphenous nerve stimulation during anesthesia [photographs, negative], undated
51	87	235 monkey columns [photographs, negative], undated
51	88	236 norepinephrine vs. control LCGU [photographs, negative], undated
51	89	237 autradiographic resolutions [photographs, negative], undated
51	90	239 layer thickness 3H activity [photographs, negative], undated
51	91	240 LandR hemisphere [photographs, negative], undated
51	92	241 functional anatomy of the operational equ. of the 14c DG method [photographs, negative], undated
51	93	242 [photographs, negative], undated
51	94	243 [photographs, negative], undated
51	95	244 [photographs, negative], undated
51	96	245 olfactory bulbs [photographs, negative], undated
51	97	246 relative optical density [photographs, negative], undated
51	98	247 hot hole plug [photographs, negative], undated
51	99	248 brain standards 3H and 14c [photographs, negative], undated
51	100	249 goldfish retinas [photographs, negative], undated
51	101	250 somata cells labeled and unlabeled [photographs, negative], undated
51	102	251 cat muscle, 24c DG [photographs, negative], undated
51	103	252 3H DG water solution frozen in plasma [photographs, negative], undated
51	104	253 grain density in buccal ganglion [photographs, negative], undated
51	105	254 olfactory bulb in tiger salamander 3HDG [photographs, negative], undated
51	106	255 3HDG -- optic lobes of dorsophila melanogaster [photographs, negative], undated
51	107	256 relationship of aggression to onset of lidocaine seizures [photographs, negative], undated
51	108	257 autoradiographic calibration curves vs 3H concentration [photographs, negative], undated
51	109	258 [photographs, negative], undated
51	110	259 occular dominance newborn [photographs, negative], undated
51	111	260 position-emitting atom [photographs, negative], undated
51	112	261 [14C] and [3H] methylglucose [photographs, negative], undated
51	113	262 mid and posterior hypothalamus [photographs, negative], undated
51	114	263 anterior hypothalamus [photographs, negative], undated
51	115	264 dopamine pathways [photographs, negative], undated
51	116	265 integrated tissue specific activity [photographs, negative], undated
51	117	266 energy metabolism in the hypothalamus: effects of reproductive hormones [photographs, negative], undated
51	118	267 integrated tissue sp. ac. [photographs, negative], undated
51	119	268 integrated tissue sp. ac. [photographs, negative], undated
51	120	269 integrated tissue sp. ac. [photographs, negative], undated
51	121	270 GHB-dehydrogenase [photographs, negative], undated
51	122	271 GHB-dehydrogenase [photographs, negative], undated
51	123	272 GHB-dehydrogenase [photographs, negative], undated
51	124	273 GHB-dehydrogenase [photographs, negative], undated
51	125	274 GHB-dehydrogenase [photographs, negative], undated
51	126	275 ESN and WFN, Italy (Smith) [negatives], undated
51	127	276 columns in striate cortex (monkey) [photographs, negatives], undated
51	128	278 computer -- block diagram, undated
51	129	279 hypoxic rat injected with black microspheres, undated
51	130	280 dopaminerglic systems influence [photographs, negative], undated
51	131	281 apomorphine vs. saline on LGU [photographs, negative], undated
51	132	282 ocular dominance columns in monkey [photographs, negative], undated
51	133	283 effects of slow-wave sleep on LGU [photographs, negative], undated
51	134	284 subfornical organ in Battleboro [photographs, negative], undated
51	135	285 neural lobe LGU [photographs, negative], undated
51	136	286 two compartment model for the behavior of leucine brain -- model V [photographs, negative], undated
51	137	287 model VI for behavior of L-leucine in brain [photographs, negative], undated
51	138	288 GHB and GABA levels in rat brain [photographs, negative], undated
51	139	289 cytosol -- rat [photographs, negative], undated
51	140	290 GHB levels -- rat kidney [photographs, negative], undated
51	141	291 GHB dehydrogenase activity in rat kidney [photographs, negative], undated
51	142	292 GHB -- dehydrogenase activity in rat brain [photographs, negative], undated
51	143	293 apomorphine effect on different areas [photographs, negative], undated
51	144	294 superior cervical ganglion -- frequency [photographs, negative], undated
51	145	295 lump constant theoretical derivations [photographs, negative], undated
51	146	296 comparison -- LGU with 3H DG and 14C DG [photographs, negative], undated
51	147	298 bar test after morphine [photographs, negative], undated
51	148	299 morphine effect on LGU in brain [photographs, negative], undated
51	149	300 morphine effect on LGU in brain [photographs, negative], undated
51	150	301 fetal sheep [photographs, negative], undated
51	151	302 fetal sheep [photographs, negative], undated
51	152	303 morphine vs. control tail flick [photographs, negative], undated
51	153	304 average rate of GU for entire brain of fetal and newborn sheep, undated
51	154	305 chemical analysis of 14C DG and 14C DG-L-P in normal rats [photographs, negative], undated
51	155	306 extinction -- Icss [photographs, negative], undated
51	156	307 PCO2 and LCGU relationship [photographs, negative], undated
51	157	308 habenula afferent and efferent pathways [photographs, negative], undated
51	158	309 LGU in laboratory animals [photographs, negative], undated
51	159	310 time course of 14C DG and 14C DG-6-P [photographs, negative], undated
51	160	311 LGU and arterial PCO2 relationship [photographs, negative], undated
51	161	312 habenula and mammillary baby pathways [photographs, negative], undated
51	162	313 lateral habenula and mammillary baby pathways [photographs, negative], undated
51	163	314 [14C] deoxyglucose autoradiographs of cat brains [photographs, negative], undated
51	164	315 effect of acute morphine on GU in rat brain [photographs, negative], undated
51	165	315 effect of acute morphine on GU in rat brain [photographs, negative], undated
51	166	316 fetal sheep [photographs], undated
51	167	317 picture procedure, DG method [photographs, negative], undated
51	168	318 axotomy in hypoglossal nucleus [photographs, negative], undated
51	169	319 axotomy -- tongue functions [photographs, negative], undated
51	170	320 age-blood flow and 02 consumption [photographs, negative], undated
51	171	321 exchange of methylglucose between plasma and brain tissue [photographs, negative], undated
51	172	322 data analysis -- ipsilateral vs. contralateral [photographs, negative], undated
51	173	323 LGU stimulation pathway [photographs, negative], undated
51	174	324 3H standards calibration curves [photographs, negative], undated
51	175	325 visual deprivation protein synthesis [photographs, negative], undated
52	1	326 autoradiograph protein synthesis [photographs, negative], undated
52	2	327 LGU other connections [photographs, negative], undated
52	3	328 LGU: sensory-motor systems [photographs, negative], undated
52	4	329 LGU: forebrain terminal areas [photographs, negative], undated
52	5	330 electrode placements: contingent and non-contingent [photographs, negative], undated
52	6	331 electrode placements: stimulated and non-stimulated [photographs, negative], undated
52	7	332 3H methylglucose vs. 14C methylglucose [photographs, negative], undated
52	8	333 3H DG vs. 14C DG [photographs, negative], undated
52	9	334 morphine bar test and tail flick [photographs, negative], undated
52	10	335 [photographs, negative], undated
52	11	336 pineal body -- LGU monkey [photographs, negative], undated
52	12	337 diazepam -- LGU [photographs, negative], undated
52	13	338 TXW vs. control [photographs, negative], undated
52	14	339 cretin vs. control [photographs, negative], undated
52	15	340 TWX vs. control [photographs, negative], undated
52	16	341 physiological parameters -- day vs. night and sleep vs. awake [photographs, negative], undated
52	17	342 lesion -- lateral habenula -- LGU [photographs, negative], undated
52	18	343 fetal sheep [photographs, negative], undated
52	19	344 LGU in lateral habenula [photographs, negative], undated
52	20	348 GHB -- anaerobic and aerobic [photographs, negative], undated
52	21	349 neural structures regulating fluid balance [photographs, negative], undated
52	22	350 GHB dehydrogenase inhibitors on tissue levels of GHB [photographs, negative], undated
52	23	351 GHB -- synthesis and degradations pathways [photographs, negative], undated
52	24	352 distribution of radioactivity after various stages of fractionation [photographs, negative], undated
52	25	353 distribution of brain glycogen among fractions after extraction [photographs, negative], undated
52	26	354 brain extraction scheme 1 [photographs, negative], undated
52	27	355 brain extraction scheme 2 [photographs, negative], undated
52	28	356 histaminergic sites influence on cerebral vessels [photographs, negative], undated
52	29	357 neurotransmitter substances -- effect on pial arteriolar diameter [photographs, negative], undated
52	30	358 encaphalocoele vs. control, striate cortex of monkey [photographs, negative], undated
52	31	359 insulin -- effect on LGU [photographs, negative], undated
52	32	360 hyperglycemia vs. normal -- LGU [photographs, negative], undated
52	33	361 2-DG-6-PO4 and 2 DG-TLC of brain extracts [photographs, negative], undated
52	34	362 LGU in ganglia during stimulation (H2) in urethane anesthesia [photographs, negative], undated
52	35	363 probe track [photographs, negative], undated
52	36	364 VTA stimulation [photographs, negative], undated
52	37	365 VTA stimulation [photographs, negative], undated
52	38	366 amphetamine -- LGU [photographs, negative], undated
52	39	367 amphetamine -- locomotor and stereotypy scores [photographs, negative], undated
52	40	368 amphetamine [photographs, negative], undated
52	41	369 amphetamine [photographs, negative], undated
52	42	370 amphetamine [photographs, negative], undated
52	43	371 angiotensis II and saralasin [photographs, negative], undated
52	44	372 angiotensinard saralasin [photographs, negative], undated
52	45	373 apomorphine [photographs, negative], undated
52	46	374 apomorphine [photographs, negative], undated
52	47	375 subfornical organ and septal triangular N. -- LGU [photographs, negative], undated
52	48	376 subformical organ and septal tricular N. -- LGU [photographs, negative], undated
52	49	377 sheep LCGU -- pre and postnatal [photographs, negative], undated
52	50	378 caffeine -- LGU [photographs, negative], undated
52	51	379 caffeine -- LGU [photographs, negative], undated
52	52	380 EAS [photographs, negative], undated
52	53	381 female rats during cycle [photographs, negative], undated
52	54	382 electrical stimulation on pineal gland [photographs, negative], undated
52	55	383 female rats during cycle [photographs, negative], undated
52	56	384 model I -- leucine traveling BBB [photographs, negative], undated
52	57	385 percent change of protein synthesis, glucose utilization and relative twitch [photographs, negative], undated
52	58	386 glucose utilization in menstruating rats [photographs, negative], undated
52	59	387 postral calcarin fissure [photographs, negative], undated
52	60	388 optic radiation tract section [photographs, negative], undated
52	61	389 eye occlusion striate cortex [photographs, negative], undated
52	62	390 ambient light markings, striate cortex [photographs, negative], undated
52	63	391 eye occlusion lateral geniculate [photographs, negative], undated
52	64	392 general equ. for measurement of reaction rates with tracers [photographs, negative], undated
52	65	394 [125I] HIPDM and metabolic products in blood [photographs, negative], undated
52	66	395 molecular structure of HIPDM [photographs, negative], undated
52	67	396 [125I] HIPDM single pass extraction [photographs, negative], undated
52	68	397 super optical nucleus, salt loading [photographs, negative], undated
52	69	398 senescence [photographs, negative], undated
52	70	399 maturescence [photographs, negative], undated
52	71	400 LGU % change vs. stimulation frequency [photographs, negative], undated
52	72	401 sciatic nerve stim. LGU in spinal cord and dorsal root ganglia [photographs, negative], undated
52	73	402 water saturated vs. water deprived [photographs, negative], undated
52	74	403 water sated vs. H2O deprived [photographs, negative], undated
52	75	404 water sated vs. H2O deprived [photographs, negative], undated
52	76	405 self-stimulation chapter [photographs, negative], undated
52	77	406 self stim. cocaine/d-amphetamine/morphine [photographs, negative], undated
52	78	407 criteria for adequate psychophysical threshold determination [photographs, negative], undated
52	79	408 self stimulation [photographs, negative], undated
52	80	409 self stim. % response vs. ua [photographs, negative], undated
52	81	410 self stim. X Z score vs. dose [photographs, negative], undated
52	82	411 running speed vs. log pulses per reward [photographs, negative], undated
52	83	412 self-stimulation (graphic) [photographs, negative], undated
52	84	413 response rate vs. intensity (base line drug) [photographs, negative], undated
52	85	414a self stimulation pre/post responses [photographs, negative], undated
52	86	414b acute dehydration [photographs, negative], undated
52	87	415 acute dehydration [photographs, negative], undated
52	88	416 (spinal cord ) acute dehydration [photographs, negative], undated
52	89	417 adrenelectomy and dexamethason [photographs, negative], undated
52	90	418 nerve stimulation -- dorsal root ganglion [photographs, negative], undated
52	91	419 paraventricular nucleus -- acute adrenalectomy [photographs, negative], undated
52	92	420 dehydration [photographs, negative], undated
52	93	421 plasma and brain, deoxyglucose and deoxyglucose -- phosphate [photographs, negative], undated
52	94	422 arterial plasma DG*/G vs. time [photographs, negative], undated
52	95	423 pituitary neural lobe, water sated/water deprived [photographs, negative], undated
52	96	424 septal triangular nucleus [negative], undated
52	97	425 subfornical organ [photographs, negative], undated
52	98	426 latero-lateral habenula [photographs, negative], undated
52	99	427 spinal cord sciatic nerve stimulation [photographs, negative], undated
52	100	428 plasma concentration (arterial and venous) vs. time [photographs, negative], undated
52	101	429 pathways of glucose metabolism [photographs, negative], undated
52	102	430 uptake of [32P] glucose-6-phosphate [photographs, negative], undated
52	103	431 loss of label rates of [2-3H] glucose and [U14C] glucose in brain [photographs, negative], undated
52	104	432 electrical stim. of sciatic nerve on LGU in spinal cord [photographs, negative], undated
52	105	433 fractions of total tissue 14c content in form of free [14c] deoxyglucose in brain [photographs, negative], undated
52	106	434 time courses of [14c] DG and 14c DG-6-P, undated
52	107	435 measured and theoretical time courses of [14c] DG-6-P in brain [photographs, negative], undated
52	108	436 arteriovenous differences of [14c] glucose and [14c] DG [photographs, negative], undated
52	109	437 newborn lamb [photographs, negative], undated
52	110	438 comparative rates of loss of label from 2-[3H] glucose and, undated
52	111	439 nonacidic compounds w/vicinal cis diol. Groups [photographs, negative], undated
52	112	442 effects of fasting on tissue levels of GHB [photographs, negative], undated
52	113	443 biosynthesis of GHB by intact mitochondria [photographs, negative], undated
52	114	444 rates of glucose utilization in rat cervical ganglion [photographs, negative], undated
52	115	445 representative values for LCGU in conscious albino rat and monkey, undated
52	116	446 [photographs, negative], undated
52	117	447 cretin vs. control [photographs, negative], undated
52	118	448 parasaggittal blindspot [photographs, negative], undated
52	119	449 cretin vs. control [photographs, negative], undated
52	120	450 cretin vs. control [photographs, negative], undated
52	121	451 refused monkey cortical section [photographs, negative], undated
52	122	454 E-cat scan of normal brain after injection of [18-F] fluorodeoxyglucose[photographs, negative], undated
52	123	455 [photographs, negative], undated
52	124	456 3H/14C ration in blood glucose [photographs, negative], undated
52	125	457 pathways of GHB metabolism [photographs, negative], undated
52	126	458 LGU in cervical ganglion [photographs, negative], undated
52	127	459 [photographs, negative], undated
52	128	460 simulation effects of frequency on LGU [photographs, negative], undated
52	129	461 effects of acute dehydration on LBG in subfornical organ [photographs, negative], undated
52	130	462 effects of acute dehydration on LGU in paracentricular nucleus [photographs, negative], undated
52	131	463 effects of DD AVP on LGU of septaltriangular nucleus [photographs, negative], undated
52	132	464 effects of DD AVP on LGU of lateral habenula nucleus, subfornical organ and paracentricular nucleus [photographs, negative], undated
52	133	465 Krebs cycle [photographs, negative], undated
52	134	466 Krebs cycles [photographs, negative], undated
52	135	467 metabolism of carbohydrates [photographs, negative], undated
52	136	468 metabolism of carbohydrate w/2-DG and 2-DG-6-P [photographs, negative], undated
52	137	469 [photograph], undated
52	138	470 G-6-P derivative of glucose fraction separated by chromatography [photographs, negative], undated
52	139	471 separation of glucose by column and paper chromatography [photographs, negative], undated
52	140	472 MPTP and L-DOPA [photographs, negative], undated
52	141	473 MPTP and L-DOPA [photographs, negative], undated
52	142	474 Estrus cycle [photographs, negative], undated
52	143	475 dose dependent of methylphoedine [photographs, negative], undated
52	144	476 DPTP and L-DOPA [photographs, negative], undated
52	145	477 G-6-P and DG-6-P activities in rat tissues [photographs, negative], undated
52	146	478 LGU in iodomethacin and dexamethasone [photographs, negative], undated
52	147	479 radiochemical heterogeneity of eluate in Dowex-1-borate column [photographs, negative], undated
52	148	480 theoretical time courses of [14c] DG-6-P in brain [photographs, negative], undated
52	149	481 glucose-6-[32p] phosphate arterial and cerebral venous concentrations [photographs, negative], undated
52	150	482 [14c] G-6-P single pass extraction fraction, undated
52	151	484 time courses of [14C] DG and [14C] DG-6-P [photographs, negative], undated
52	152	485 effects of antidromic stimulation on the rates of glucose utilization [photographs, negative], undated
53	1	486 plasma concentration vs. rate constants [photographs, negative], undated
53	2	487 difference in glucose utilization vs. frequency of stimulation (Hz) [photographs, negative], undated
53	3	488 plasma glucose concentration vs. glucose infusion rate [photographs, negative], undated
53	4	489 lumped constant at different plasma glucose levels [photographs, negative], undated
53	5	490 arterial and venous concentrations [photographs, negative], undated
53	6	491 self stimulation [photographs, negative], undated
53	7	492 self stimulation II [photographs, negative], undated
53	8	493 LGN in intact binocular vision vs. chronic monocular deprivation [photographs, negative], undated
53	9	494 dorsal root ganglion [photographs, negative], undated
53	10	495 monkey arm movement [photographs], undated
53	11	496 estimation of rate constants for dephosphorylation [photographs, negative], undated
53	12	497 LCGU in globus pallidus and subthalmic nucleus [photographs, negative], undated
53	13	498 DG6P by NMR vs. DG6P [GC-MS] [photographs, negative], undated
53	14	499 LCGU in sensorimotor cortex and ventromedial thalamus [photographs, negative], undated
53	15	500 LCGU [photographs, negative], undated
53	16	501 % change in G.U. from no stimulation control values [photographs, negative], undated
53	17	502 % change in G.U. from no stimulation control values [photographs, negative], undated
53	18	503 % change in GU (IPSI vs. contralateral) [photographs, negative], undated
53	19	504 LCGU in medial prefrontal and anterior cingulated cortex [photographs, negative], undated
53	20	505 % change in GU, anterior cingulated and dorsomedial caudate [photographs, negative], undated
53	21	506 changes in metabolic activity during self-stimulation [photographs, negative], undated
53	22	507 behaviors associated w/self-stimulation to the ventral mid brain [photographs, negative], undated
53	23	508 concentrations of glucose, glycogen and lactate [photographs, negative], undated
53	24	509 [14c] DG concentration in plasma, gray and white [photographs, negative], undated
53	25	510 % of 14c as 14c-DG/amount of 14c-DGP found after single injection [photographs, negative], undated
53	26	511 principle of the assay of glucose-6-P in vivo by selective detritiation of [2-3H]G [photographs, negative], undated
53	27	512 incorporation of 2-[14c] deoxyglucose into glycogen a [photographs, negative], undated
53	28	513 GU in control post-radiation: 4 days and 4 weeks [photographs, slides], undated
53	29	514 glucose infusion rate[photographs, negative], undated
53	30	515 lumped constant vs. arterial plasma glucose [photographs, negative], undated
53	31	516 arterial plasma glucose concentration vs. duration of infusion [photographs, negative], undated
53	32	517 determination of lumped constants during hyperglycemia state [photographs, negative], undated
53	33	518 arterial plasma glucose concentration vs. rate constants in grey and white matter [photographs, negative], undated
53	34	519 lumped constant vs. arterial plasma glucose concentration [photographs, negative], undated
53	35	520 lack of uptake of [32p] G-6-P [photographs, negative], undated
53	36	521 Hawkins brain, DG-6-P graphs [photographs, negative], undated
53	37	522 stimulation of sciatic nerve [photographs, negative], undated
53	38	523 cytochemical localization of G-6-P [photographs, negative], undated
53	39	524 localization of G6-pase in a nerve cell [photographs, negative], undated
53	40	525 effects of catecholamines of cerebral circulation and metabolism [photographs, negative], undated
53	41	526 eye occlusion striate cortex [photographs, negative], undated
53	42	527 control, Tx and Tx + warm [photographs, negative], undated
53	43	528 effects of amphetamines on brain glucose metabolism D [photographs, negative], undated
53	44	530 Ci*/cp* vs. real time (square wave experiment) [photographs, negative], undated
53	45	531 influence of duration of experimental period on weighted ave G.U. [photographs, negative], undated
53	46	532 Ci*/Cp* vs. stretch time [photographs, negative], undated
53	47	533 Ci*/Cp* vs. real time [photographs, negative], undated
53	48	534 operational equation with 5 rate constants [photographs, negative], undated
53	49	535 LCGU vs. methylphenidate [photographs, negative], undated
53	50	536 methlyphenidate [photographs, negative], undated
53	51	537 LCGU vs. methylphenidate [photographs, negative], undated
53	52	538 the localization of G-6-pase in nerve cell of cerebral cortex [photographs, negative], undated
53	53	540 G-6-P localization in liver [photographs, negative], undated
53	54	541 effects of L-DOPA treatment on LCGU [photographs, negative], undated
53	55	542 L-DOPA effects on LCGU in normal and MPTP-treated monkeys [photographs, negative], undated
53	56	543 % dephosphorylation vs. % dephosphorylation of DG-6-P [photographs, negative], undated
53	57	544 stretch time vs. apparent distribution space in sensorimotor cortex [photographs, negative], undated
53	58	545 weighted average tissue concentration [photographs, negative], undated
53	59	546 Ci*(T)/Cp*(T) vs. stretch time in sensory cortex [photographs, negative], undated
53	60	547 Ci*(T)/Cp*(T) vs. stretch time in hypothalamus [photographs, negative], undated
53	61	548 substantia nigra (pars reticulate) [photographs, negative], undated
53	62	549 N20 VOI % vs. min. of inhalation [photographs, negative], undated
53	63	550 apparent distributions space vs. real time [photographs, negative], undated
53	64	551 Ci*(T)/Cp* vs. real time (square wave experiments) [photographs, negative], undated
53	65	552 body temp. vs. time (min. after injection) [photographs, negative], undated
53	66	553 N moles GHB/g brain vs. dose of GHB (mg/kg) [photographs, negative], undated
53	67	554 t (C at 0-60 min.) vs. dose of GHB (mg/kg) [photographs, negative], undated
53	68	555 cerebral and cerebellar cortex [photographs, negative], undated
53	69	556 white matter structures [photographs, negative], undated
53	70	557 % error of prediction: s. colliculus, pontine gray matter and sunstantia nigra [photographs, negative], undated
53	71	558 deep cerebral gray structures [photographs, negative], undated
53	72	559 effect of L-gulonate or D-glucuronate in plasma disappearance curve (GHB) [photographs, negative], undated
53	73	560 weighted LCGU vs. time conc. rem sleep [photographs, negative], undated
53	74	561 % error of prediction [photographs, negative], undated
53	75	562 rate constants [photographs, negative], undated
53	76	563 model and equa. for estimation of rate constants for dephosphorylation [photographs, negative], undated
53	77	565 weighted average tissue concentration [photographs, negative], undated
53	78	566 pontine gray [photographs, negative], undated
53	79	567 globus pallidus [photographs, negative], undated
53	80	568 cerebellar cortex [photographs, negative], undated
53	81	569 corpus callosum [photographs, negative], undated
53	82	570 arterial plasma concentration [photographs, negative], undated
53	83	571 arterial plasma concentration [photographs, negative], undated
53	84	572 sensory cortex [photographs, negative], undated
53	85	573 influence of duration of experimental period on weighted ave. G.U. [photographs, negative], undated
53	86	574 total DG-6-P concentration, undated
53	87	575 concentration -- weighted fraction of total time spent in rem sleep [photographs, negative], undated
53	88	576 [14c] DG concentration vs. time [photographs, negative], undated
53	89	577 relative 3H/14c (sample/injectant) [photographs, negative], undated
53	90	578 labeled compounds remaining after hexokinase purification step [photographs, negative], undated
53	91	579 pyrrolidone-5-carboxylate is a major contaminant of huang and veech ???????glucose' [photographs, negative], undated
53	92	580 % total DPM and relative 3H/14C ratio [photographs, negative], undated
53	93	581 labeled contaminants in huang and veech ???????glucose' [photographs, negative], undated
53	94	582 lability of [2-3H, U-14C] glucose during purification, undated
53	95	583 labeled compounds remaining after glucose oxidase purification step [photographs, negative], undated
53	96	584 glucose purification [photographs, negative], undated
53	97	585, undated
53	98	586 LCGU in rem sleep [photographs, negative], undated
53	99	587 LCGU vs. time concentration slow wave sleep [photographs, negative], undated
53	100	588 washout correction experiment [photographs, negative], undated
53	101	589 ulisse [photographs, negative], undated
53	102	590 ulisse [photographs, negative], undated
53	103	591 ulisse [photographs, negative], undated
53	104	592 ulisse [photographs, negative], undated
53	105	593 pet scan -- Italian [photographs, negative], undated
53	106	594 cerebellar cortex [photographs, negative], undated
53	107	595 internal capsule [photographs, negative], undated
53	108	596 tissue 2DG and 2DG-6-P, undated
53	109	597 relationship between cerebral oxygen consumption and G.U. [photographs, negative], undated
53	110	598 body temp. vs. time [photographs, negative], undated
53	111	599 lumped constant in several species [photographs, negative], undated
53	112	600 rate constants for 3-0-methylglucose [photographs, negative], undated
53	113	601 ratio of antibody to cytosol or to homogenate [photographs, negative], undated
53	114	602 rate constants for dephosphorylation [photographs, negative], undated
53	115	603 blood flow vs. age [photographs, negative], undated
53	116	604 patlak plot [photographs, negative], undated
53	117	605 equa. for estimation of rate constants for dephosphorylation [photographs, negative], undated
53	118	606 GH B in cytosol [photographs, negative], undated
53	119	607 GHB dehydrogenase vs. sod. valproate [photographs, negative], undated
53	120	608 brain growth in different species in relation to birth [photographs, negative], undated
53	121	609 parkisonian syndrome [photographs, negative], undated
53	122	610 [14C] DG and [14C] DG-6-P concentration vs. time [photographs, negative], undated
53	123	612 theoretical calculation of [14C] DG-6- P [photographs, negative], undated
53	124	613 2 DG and rem sleep [photographs, negative], undated
53	125	614 GHB activity vs. time [photographs, negative], undated
53	126	615 time course of average brain DG-6-P concentration [photographs, negative], undated
53	127	616 DG-6-P glucose clamp [photographs, negative], undated
53	128	617 futile cycle associated w/ G6P (G6 pase) [photographs, negative], undated
53	129	618 Huang and Beech TLC contaminants [photographs, negative], undated
53	130	619 L-DG and enzyme [photographs, negative], undated
53	131	620 SSA formed vs. pH [photographs, negative], undated
53	132	621 SSA and [symbol] -- KG [photographs, negative], undated
53	133	622 [symbol] -- KG, GHB and enzyme [photographs, negative], undated
53	134	623 plasma glucose in normoglycemia [photographs, negative], undated
53	135	625 plasma glucose in hyperglycemia [photographs, negative], undated
53	136	626 pulse and square wave in S. N. [photographs, negative], undated
53	137	627 pulse and sq. wave in sensory cortex [photographs, negative], undated
53	138	628 pulse and sq. wave in dorsal thalamus [photographs, negative], undated
53	139	629 pulse and sq. wave in whole brain [photographs, negative], undated
53	140	630 pulse and sq. wave in cerebellar cortex [photographs, negative], undated
53	141	631 pulse and sq. wave in hypothalamus [photographs, negative], undated
53	142	632 pulse and sq. wave in internal capsule [photographs, negative], undated
53	143	633 L-hydroxyglutaric acid TMS [photographs, negative], undated
53	144	634 V-hydroxybutyric acid vs. temp. [photographs, negative], undated
53	145	635 veech contaminants [photographs, negative], undated
53	146	636 pontine gray (Pulse and SQ. Wave) [photographs, negative], undated
53	147	637 plasma glucose in hypoglycemia [photographs, negative], undated
53	148	638 veech column separation [photographs, negative], undated
53	149	639 glucose utilization in sq. wave [photographs, negative], undated
53	150	640 duration of experimental period on weighted G.U. (pulse) [photographs, negative], undated
53	151	641 after derivatization of glucose w/ hexokinase and G. oxidase [photographs, negative], undated
53	152	642 veech analysis of contaminants [photographs, negative], undated
53	153	643 brain extract -- dowex (Veech) [photographs, negative], undated
53	154	644 veech contaminants after separation [photographs, negative], undated
53	155	645 plasma glucose vs. pulse and sq. wave [photographs, negative], undated
53	156	646 rate constants vs. length of experiment [photographs, negative], undated
53	157	647 CBF in normal mouse [photographs, negative], undated
53	158	648 plasma glucose concentration in normoglycemia[photographs, negative], undated
53	159	649 plasma glucose concentration in hypoglycemia [photographs, negative], undated
53	160	650 plasma glucose concentration in hyperglycemia, undated
54	1	651 cocaine / activity [photographs, negative], undated
54	2	652 cocaine -- gluc. Util. vs. activity [photographs, negative], undated
54	3	653 acute MPTP : olive [photographs, negative], undated
54	4	654 MPTP acute : nigra [photographs, negative], undated
54	5	655 mouse blood flow [photographs, negative], undated
54	6	656 arithmetic average rate constants [photographs, negative], undated
54	7	657 hypothalamus [photographs, negative], undated
54	8	658 substantia nigra reticulata [photographs, negative], undated
54	9	659 rate constants determined for cerebellar cortex [photographs, negative], undated
54	10	660 rate constants -- SN ret. [photographs, negative], undated
54	11	661 constants -- internal capsule [photographs, negative], undated
54	12	662 rate constants -- hypothalamus [photographs, negative], undated
54	13	663 arithmetic average rate constants for white matter [photographs, negative], undated
54	14	664 mouse blood flow rate corrections [photographs, negative], undated
54	15	665 LCBF VS. LCGU in normal mice [photographs, negative], undated
54	16	666 LCBF VS. LCGU in normal mice [photographs, negative], undated
54	17	667 cocaine -- activity vs. time after 2 DG. [photographs, negative], undated
54	18	668 rate constants -- composite [photographs, negative], undated
54	19	669 metabolites -- dowex -- 1 -- formate column [photographs, negative], undated
54	20	670 methyl glucose plasma concentration vs. time [photographs, negative], undated
54	21	671 elution of methylglucose [14C] vs. [U -- 14C ] [photographs, negative], undated
54	22	672 hexokinase on dowex -- 1 -- formate effluent [photographs, negative], undated
54	23	673 plasma glucose on dowex in normoglycemia and hyperglycemia [photographs, negative], undated
54	24	674 cocaine LCGU vs. dose [photographs, negative], undated
54	25	675 drugs and LCGU [photographs, negative], undated
54	26	676 cocaine -- LCGU in nucl. acc. and SN.[photographs, negative], undated
54	27	677 neurotransmitters and basal ganglia [photographs, negative], undated
54	28	678 main connections of the nigrostriatal system [photographs, negative], undated
54	29	679 diagram of basal ganglia [photographs, negative], undated
54	30	680 [photographs, negative], undated
54	31	682 hypergly. methyl glucose [photographs, negative], undated
54	32	683 extractions of sugars [photographs, negative], undated
54	33	684 % of 14C applied to dowex -- 1 -- formate column [photographs, negative], undated
54	34	685 extraction of metabolites [photographs, negative], undated
54	35	686 diagram of precursor pool [photographs, negative], undated
54	36	687 10K model [photographs, negative], undated
54	37	688 plasma glucose in hyperglycemia [photographs, negative], undated
54	38	689 plasma glucose in normoglycemia [photographs, negative], undated
54	39	690 plasma glucose in hypoglycemia [photographs, negative], undated
54	40	691 5 rate constants model [photographs, negative], undated
54	41	692 fractional rate of product loss [photographs, negative], undated
54	42	693 LCGU vs. med. geniculate [photographs, negative], undated
54	43	694 triopental and celiac ganglionectomy [photographs, negative], undated
54	44	695 Gl. util. thiopental and celiac ganglionectomy [photographs, negative], undated
54	45	696 G.U. thiopental and celiac ganglionectomy [photographs, negative], undated
54	46	697 G.U. thiopental and celiac ganglionectomy [photographs, negative], undated
54	47	698 lumped constants in normo and hypo glycemia [photographs, negative], undated
54	48	699 lumped constants in normo, hypo and hyper glycemia [photographs, negative], undated
54	49	700 lumped constants in arterial and venous concentration [photographs, negative], undated
54	50	701 methylglucose sections [photographs, negative], undated
54	51	702 statistical analysis, experiments w/ sq. wave [photographs, negative], undated
54	52	703 rate constants used in calculation of LCGU [photographs, negative], undated
54	53	704 statistical analysis experiments w/ pulse input [photographs, negative], undated
54	54	705 arterial plasma concentration in exp. animals [photographs, negative], undated
54	55	706 LCGU 3K and 4K models [photographs, negative], undated
54	56	707 rate constants -- sq. wave and pulse [photographs, negative], undated
54	57	708 methylglucose sections [photographs, negative], undated
54	58	709 lumped constants w/ sq. wave [photographs, negative], undated
54	59	710 plasma glucose on dowex -- normo, hypo and hyper glycemia [photographs, negative], undated
54	60	711 extraction of metabolites [photographs, negative], undated
54	61	712 recovered DPM [photographs, negative], undated
54	62	713 recovery of sugars from dowex [photographs, negative], undated
54	63	714 correction (Veech) for blood remaining in brain [photographs, negative], undated
54	64	715 r vs. brain glucose concentration [photographs, negative], undated
54	65	716 hexose distribution ratios vs. brain glucose level [photographs, negative], undated
54	66	717 hexose distribution.ratios vs. plasma levels [photographs, negative], undated
54	67	718 non -- acidic, non -- phosph. metabolites [photographs, negative], undated
54	68	719 labeled Non -- acidic and non -- phosphor. metabolites [photographs, negative], undated
54	69	720 phosphorylation coefficient vs. plasma concentration [photographs, negative], undated
54	70	721 elodea cell summary [photographs, negative], undated
54	71	722 methylglucose sections [photographs, negative], undated
54	72	723 elodea cells [photographs, negative], undated
54	73	724 methylglucose mouse [photographs, negative], undated
54	74	725 methylglucose distribution ratio [photographs, negative], undated
54	75	726 steady -- state methylgl. distribution ratio [photographs, negative], undated
54	76	727 total tissue radioactivity [photographs, negative], undated
54	77	728 rate constants estimated from DG and DG-6-P concentration [photographs, negative], undated
54	78	729 rate constants estimated from total tissue radioactivity [photographs, negative], undated
54	79	730 heterogeneous tissue [photographs, negative], undated
54	80	731 rate constant for phosphorylation [photographs, negative], undated
54	81	732 4K rate constants gray matter [photographs, negative], undated
54	82	734 equilibrium MG tissue/ plasma [photographs, negative], undated
54	83	735 time course of DG metabolites [photographs, negative], undated
54	84	736 r vs. Ce [photographs, negative], undated
54	85	737 lumped constant [photographs, negative], undated
54	86	738 brain glucose util. in hyperglycemia [photographs, negative], undated
54	87	739 monkey vs. cortex [photographs, negative], undated
54	88	740 rate constants for various levels of hyperglycemia [photographs, negative], undated
54	89	741 influence of rate constants on integrated pool S.P. [photographs, negative], undated
54	90	744 lumped constant at various levels of hyperglycemia [photographs, negative], undated
54	91	745 effects of hyperinsulinemia [photograph, negative], undated
54	92	748 GHB and temp. vs. time [photographs, negative], undated
54	93	757 [symbol] including equation [photograph], undated
54	94	760 diagram of freely moving rat [photographs, negative], undated
54	95	765 LCGU in sup. collic., cerebellar cortex, med. gen. and int. cap. [negative], undated
54	96	766 LCGU in sup. collic. hypothalamus, int. cap. And rate constants [photographs, negative], undated
54	97	777 autoradiographic film test [photographs, negative], undated
54	98	779 L-thyroxine uptake by brain [photographs, negative], undated
54	99	795 pictorial diagram, protein synth. [photograph], undated
54	100	799 distribution of CO2 in cells [negative], undated
54	101	800 CO2 fixation in cell cultures [photographs], undated
54	102	801 DNA/stairs -- joke [photographs, negative], undated
54	103	811 equation for deoxyglucose methods [photograph], undated
54	104	812 functional anatomy of 2 DG equ. [photographs, negative], undated
54	105	813 tower of matches -- Joke [photographs, negative], undated
54	106	814 nut and bolt -- joke [photographs, negative], undated
54	107	816 equation for Patlak plot [photograph], undated
54	108	817 rates fo hexoses transport [photograph], undated
54	109	818 time courses uptake [photograph], undated
54	110	819 equilibrium of CH3-glucose tissue [photograph], undated
54	111	820 Michaelis-Menten kinetics [photograph], undated
54	112	821 reaction catalyzed by pyruvate carboxylate [photograph], undated
54	113	823 DG-G-P concentration in tissue reflects true average of rates of phosphorylation [photograph], undated
54	114	824 total mixed tissue of two compartments [photograph], undated
54	115	825 effect of glutamine conc. In culture medium [photograph], undated
54	116	826 effect of varying the timing of medium change [photograph], undated
54	117	827 role of individual medium constituents [photograph], undated
54	118	828 glutamine is source of glutamate in culture medium [photograph], undated
54	119	829 destruction of cultures with a brief pulse of medium [photograph], undated
54	120	830 destruction of cultures during medium change (buffer) [photograph], undated
54	121	831 destruction of cell cultures: protection by NMDA [photograph], undated
54	122	832 3-H dopamine uptake vs. concentration of antagonists [photograph], undated
54	123	833 brief exposure to fresh medium (pulse) [photograph], undated
54	124	834 dual pathway for the oxidation of [symbol]-hydrobutyrate [photograph], undated
54	125	835 tech notes: whole-body autoradiographs of mouse for G-6-p-ase activities [photograph], undated
54	126	836 release of dopamine by added ligands [photograph], undated
54	127	837 effects of antagonists on resistance [photograph], undated
54	128	838 percentage uptake of 3-H dopamine vs. concentration of agonists [photograph], undated
54	129	839 effect of glutamine concentration In culture medium [photograph], undated
54	130	840 release of 3-H dopamine from pre-labelled cultures [photograph], undated
54	131	841 reaction catalyzed by the mitochondrial hydroxyacid oxoacid transhydrogenase [photograph], undated
54	132	842 neurotransmitters production cycle [photograph], undated
54	133	843 model of DG method including G-6 p-ase activity [photograph], undated
54	134	844 lumped constant vs. arterial plasma glucose conc. [photograph], undated
54	135	845 DG model including G-6-p-ase activity [photograph], undated
54	136	846 DG model including G-6-p-ase activity, undated
54	137	848 relationships among arterial plasma and brain G. concentration and CMRglc [photograph], undated
54	138	849 apparent dist. Space (whole brain, pont. Gray, cerebral cortex) [photograph], undated
54	139	850 apparent dist. Space (sub. nigra, sens. cortex, int. capsule [photographs, negative], undated
54	140-146	851-857 scientific couns. [not photo], undated
54	147	871 rt. hypoglossal nucleus and rt. nucleus tractus solitarius [photographs], undated
54	148	872 MPTP -- treated and normal [photographs], undated
54	149	873 human -- eyes open and closed [photographs], undated
54	150	875 DG in working monkey spinal cord [photographs], undated
54	151	887 LCGU spinal cord (monkey) [photographs], undated
54	152	889 LCGU spinal cord [photographs], undated
54	153	910 MPTP lab. of cerebral metabolism [photographs], undated
54	154	943 monkey using left arm -- Cerebellum [photographs], undated
54	155	944 monkey using left arm [photographs], undated
54	156	945 paraventricular nucleus [photographs], undated
54	157	946 superior cervical ganglia [photographs], undated
54	158	947 whisker barrel [photographs], undated
54	159	947 whisker barrel CBF paper [photographs, negative], undated
54	160	948 methyl glucose in brain [photographs], undated
54	161	949 monkey using left arm -- Parietal [photographs], undated
54	162	958 pituitary [photographs], undated
54	163	963 monkey using left arm [photographs], undated
54	164	964 striate cortex [photographs], undated
54	165	1001 postnatal change in cerebral blood flow, undated
54	166	1002 phoenoxybenzamine [photograph], undated
54	167	1012 monkey striate cortex (awake vs. sleep) [photographs], undated
54	168	1013 hypoglossal nucleus and tractus solitarius [photographs], undated
54	169	1014 adrenalectomy and dexamethasone [photographs], undated
54	170	1062 monkey ocular dominance columns [photographs], undated
54	171	1126 Joseph Barcroft on oxygen, undated
54	172	1126 quote: oxygen required for work, undated
54	173	1127 methylglucose equilibrium tissue, undated
54	174	1127 pet diagram, undated
54	175	1128 rate constants" for efflux of DG/phosphorylation", undated
54	176	1129 behavior of DG in heterogeneous tissue, undated
54	177	1130 equation for rate of GU, undated
54	178	1131 behavior of DG in heterogeneous tissue, undated
54	179	1132 heterogeneous model (no loss), undated
54	180	1133 behavior of DG in heterogeneous tissue (no loss), undated
54	181	1134 DG method assumptions, undated
54	182	1135 Y CMR glc. vs. time, undated
54	183	1136 K4 to K3 in simulated mixed tissue, undated
54	184	1137 tissue concentration of DG, DG-6-P and radioactivity estimate with hetero tissue model, undated
54	185	1138 homogeneous tissue: estimated DG, DG-6-P conc., undated
54	186	1139 DG, DG-6-P and radioactivity concentration For simulated heterogeneous tissue, undated
54	187	1140 behavior of DG in heterogeneous tissue, undated
54	188	1141 behavior of DG in homogeneous tissue and loss (4K), undated
54	189	1142 behavior od DG in homogeneous tissue -- 3K, undated
54	190	1143 design for experimental determining of glucose utilization rate, undated
54	191	1144 equation for rate of glucose utilization, undated
54	192	1145 heterogeneous vs. homogeneous -- CMR, undated
54	193	1146 heterogeneity model for DG in tissue, undated
54	194	1147 equation for rate of G.U. (no loss), undated
54	195	1148 emperor's clothes -- quote, undated
54	196	1149 truth / stumble -- quote, undated
54	197	1150 rate constants for various arterial plasma, undated
54	198	1151 model of DG method including G-6-P-ase, undated
54	199	1161 methyl glucose dist. ratio [photographs, negative], undated
54	200	1178 astroglial metabolism, undated
54	201	1179 astroglial metabolism plus potassium, undated
54	202	1180 monkey cortical area [photographs, negative], undated
54	203	1181 MRI + PET in human [photographs], undated
54	204	1185 diagram of AV exchange [photographs, negative], undated
54	205	1186, undated
54	206	1187 on the regulation of the blood supply of the brain, undated
54	207	1189 amino acid incorporation, undated
54	208	1190 regional [symbol] protein synthesis, undated
54	209	1191 Vmax / Km for NADPH, undated
54	210	1192 NADPH production, undated
54	211	1193 kinetic constants for inhibition of GHB-dehydrogenase, undated
54	212	1194 rate of transhydrogenase reaction, undated
54	213	1195 stoichiometry of [symbol]-HB, undated
54	214	1198A steady state ratios of [3H] in tissue pools to plasma, undated
54	215	1200A time courses of plasma, undated
54	216	1201A schematic of the definition of [symbol], undated
54	217	1202 regional values of [symbol] in adult males, undated
54	218	1203A effects of unilateral electrical stimulation, undated
54	219	1204A effects of lt. thiopental anesthesia, undated
54	220	1205A time course of plasma, undated
54	221	1206A denominator of the operational equation, undated
54	222	1207 values of [symbol] and rates of protein in adult male rat, undated
54	223	1208 rate of leucine into protein, undated
54	224	1209 equation of the L-[1-14C] leucine method, undated
54	225	1210 higher brain functions in humans, undated
54	226	1210A, undated
54	227	1211 functional state on protein synthesis, undated
54	228	1212 effects of aging on rates, undated
54	229	1213 values of [symbol] WB in the rat, undated
54	230	1214 effects of unilateral hypoglossal axotomy, undated
54	231	1215 [psi] v. [symbol] in the whole brain, undated
54	232	1216 L-[1-14C] leucine method, undated
54	233	1217 constant C*p for a long experimental interval, undated
54	234	1220 quote from W. Thomson, undated
54	235	1221 substances affecting phosphofructokinase activity, undated
54	236	1222 operational equation of the L-[1-14C] leucine method, undated
54	237	1224 biochemical reaction in vivo, undated
54	238	1225 human myelin basic proteins, undated
54	239	1231, undated
54	240	1232 cerebral blood flow (chat) [photographs, negative], undated
54	241	1233 CBF vs. aging [photographs, negatives], undated
54	242	1234 rCMRglc. vs. tme [photographs, negative], undated
54	243	1235 rate constant vs. end time of last scan [photographs, negative], undated
54	244	1236 K vs. end time of last scan [photographs], undated
55	1	1237 rCMRglc. vs. time [photographs, negative], undated
55	2	1238 gluc. util. vs. midscan time [photographs, negative], undated
55	3	1239 glucose vs. fructose as phosphate donor [photographs, negative], undated
55	4	1240 distribution of 14C in arterial metabolites [photographs, negative], undated
55	5	1242 DG of metabolites levels vs. time of the pulse [photographs, negative], undated
55	6	1243 DPM before and after acid hydrolysis [photographs, negative], undated
55	7	1244 influence of 14C metabolites on G.U. in brain [photographs, negative], undated
55	8	1245 steady state brain -- plasma distribution ratios [photographs, negative], undated
55	9	1247 elution gradient, standards, ethanol extract [photographs, negative], undated
55	10	1249 concentration of DG-6-P in incubation vs. G-1, 6-P-2 concentration [photographs, negative], undated
55	11	1250 lumped constant -- DG vs. brain glucose content [photographs, negative], undated
55	12	1251 gradient elution and ethanol extract, undated
55	13	1252 metabolite concentration vs. incubation time [photographs, negative], undated
55	14	1253 14C --labeled metabolites in ethanol extract [photographs, negative], undated
55	15	1254 concentration of 14C compounds vs. time after DG pulse [photographs, negative], undated
55	16	1256 Huxley quote on mathematics, undated
55	17	1257 profile of acetate elution gradient [photographs, negative], undated
55	18	1259 thiopental anesthesia, undated
55	19	1260 rates of protein synthesis in adult male rat, undated
55	20	1261 L-valine flooding -- protein synthesis, acid soluble pools, undated
55	21	1262 L-valine flooding -- bound a.a. pools, undated
55	22	1263 definition of [symbol], undated
55	23	1264 value of [symbol] in hypoglossal axotomy, undated
55	24	1265 determination of [symbol], undated
55	25	1266 simple operational equation protein synthesis, undated
55	26	1267 operational equation and definitions -- protein synthesis, undated
55	27	1268 denominator of operational equation, undated
55	28	1269 electrical stimulation of sciatic nerve on protein synthesis in spinal cord and DRG, undated
55	29	1270 values of [symbol] in developing rat, undated
55	30	1271 definition of [symbol] in steady state, undated
55	31	1272 flow sheet diagram for protein synthesis experiments, undated
55	32	1273 leucine in tissue pool vs. plasma specific act., undated
55	33	1274 design protein synthesis procedure to simplify equation, undated
55	34	1275 thiopental anesthesia and protein synthesis, undated
55	35	1276 controal and protacaval shunt [photographs, negative], undated
55	36	1277 barbital foci in DG and MG [photographs, negatives], undated
55	37	1278 penicillin focus in DG and MG [photographs, negatives], undated
55	38	1279 developmental time course in kidney [photographs, negatives], undated
55	39	1280 developmental time course in brain [photographs, negatives], undated
55	40	1281 developmental time course in kidney [photographs, negatives], undated
55	41	1282 developmental time course in brain [photographs, negatives], undated
55	42	1283 antibody titration of GHBD in rat brain cytosol [photographs, negatives], undated
55	43	1284 developmental time course in kidney [photographs, negatives], undated
55	44	1285 developmental time course in brain [photographs, negatives], undated
55	45	1286 [photographs, negatives], undated
55	46	1287 effect of whisker stroking on blood flow in whisker-to-barrel pathway[photographs, negatives], undated
55	47	1303 [photographs], undated
55	48	1313 reaction sequence in amino acid incorporation into protein, undated
55	49	1314 reaction sequence in amino acid incorporation into protein, undated
55	50	1315 Lord Kelvin quote, undated
55	51	1316 C. W. Roy and C. S. Sherrington quote, undated
55	52	1317 cartoon by W. Miller, undated
55	53	1325 cat brain [photographs, negative], undated
55	54	1326 [photographs, negative], undated
55	55	1327 homogeneous and heterogeneous tissue model [photographs, negative], undated
55	56	1328 time course of measured radioactivity[photographs, negative], undated
55	57	1329 superior colliculus and lateral geniculate nucleus [photographs, negative], undated
55	58	1330 effect of n-monomethyl-L-arginine on mean arterial blood pressure in rats, undated
55	59	1331 effect of unilaterail whisker stroking on blood flow in unstimulated side of whisker to barrel pathway, undated
55	60	1332 effects of nitric oxide synthase inhibitors on arterial pressure, undated
55	61	1333 effects of nitric oxide synthase inhibitors on increases in cerebral blood flow caused by breathing 5 percent C02, undated
55	62	1334 Distribution of N-methyl-Larginine between blood and brain 10 minutes after I.V. pulse, undated
55	63	1335 effects of systemic infusion of nitric oxide synthase inhibitors on ICBF in whisker-to-barrel pathway during unilateral whisker stimulation, undated
55	64	1336 effects of intra-cisternal infusion of nitroarginine methy ester on ICBF in whisker-barrel pathway during unilateral whisker stimulation in the unanesthetized rat, undated
55	65	1337 summary, undated
55	66	1338 effects of 5 percent carbon dioxide on physiological variables in rats, undated
55	67	1339 effects of 5 percent C02 on physiological variables in rats following systemic administration of nitric oxide inhibitors, undated
55	68	1340 effects of intracisternal administration of artificial CSF and of nitroarginine on physiological variables in rats, undated
55	69	1341 [photographs, negative], undated
55	70	1342 C. W. Roy and C. S. Sherrington quote, undated
55	71	1346 Kt for brain: plasma glucose transport, undated
55	72	1347 Kt for blood-brain barrier transport of glucose from methylglucose tissue:plasma distribution ratios, undated
55	73	1348 relationship of equilibrium methylglucose tissue:plasma distribution ratio to tissue glucose content in brain, undated
55	74	1349 effects of insulin on local rates of glucose utilization in conscious rat brain, undated
55	75	1350 effects of insulin-induced hypoglycemia on local rates of cerebral glucose utilization in the rat, undated
55	76	1351 brain glucose utilization in hyperglycemia [photographs, negative], undated
55	77	1352 effects of systemic administration of NO synthase inhibitors on enzyme activities in brain, undated
55	78	1353 effects of systemic administration of NO synthase inhibitors on enzyme activities in brain, undated
55	79	1354 effects of altered arterial blood tensions of respiratory gases on cerebral blood flow and related functions in normal young men, undated
55	80	1355 effects of inhibition of nitric oxide synthesis by intravenous administration of NG-methylarginine or NG-nitroarginine on cerebral blood flow in conscious rats, undated
55	81	1356 brain glucose concentration and lumped constant, undated
55	82	1357 traits of portacaval-shunted rats, undated
55	83	1358 calculation of the rate of glucose utilization in brain, undated
55	84	1359 ammonia levels in control and portacaval-shunted rats, undated
55	85	1360 glucose and glycogen concentrations and brain:plasma distribution ratios for glucose treatment, undated
55	86	1361 steady state brain:plasma distribution ratios for [14C]methylglucose, undated
55	87	1362 glucose and glycogen concentrations and brain:plasma distribution ratios for glucose treatment, undated
55	88	1363 deoxyglucose and glucose, undated
55	89	1364 comparison of levels of ammonia, glucose and glutamine in various portacaval-shunted rats, undated
55	90	1365 glucose levels and lumped constant in portacaval shunted rats, undated
55	91	1366 effects of NOS inhibitor on increases in CBF induced by C02 inhalation in anesthetized ventilated rats, undated
55	92	1367 effects of chronic intraperitoneal administration of NO synthase inhibitor on enzyme activites in brain, undated
55	93	1368 effects of systemic administration of NO synthase inhibitors on enzyme activities in brain, undated
55	94	1369 effects of intracisternal administration of NO synthase inhibitor on enzyme activities in brain, undated
55	95	1370 visual pattern discrimination task, undated
55	96	1371 section of the optic tract and corpus callosum 'blinds' the right hemisphere, undated
55	97	1373 theory -- at equilibrium the rates of transport of methylglucose (MG), v*, to and from the brain tissue are equal, undated
55	98	1374 physiological variables before and after topical application of bicuculline and muscimol, undated
55	99	1375 preliminary experiments to evaluate the influence of bicuculline and muscimol on ICMRglc and steady state brain:plasma distribution ratio for [14C]methylglucose, undated
55	100	1376 fig. 1. Ce*/Cp* as function of Ce at Cp = 15.4 mM, undated
55	101	1377 fig. 2. Ce*/Cp* as function of Ce at Cp = 9.5 mM, undated
55	102	1378 fig. 3. Ce*/Cp* as function of Ce at Cp = 6.8 mM, undated
55	103	1379 fig. 4. Ce*/Cp* as function of Ce at Cp = 5.6 mM, undated
55	104	1380 fig. 5. Ce*/Cp* as function of Ce at Cp = 4.5 mM, undated
55	105	1381 fig. 6. Combined results: Ce*/Cp* as function of Ce when Ce is varied mainly by delivery or by the rate of glucose utilization, undated
55	106	1382 fig. 7. Combined theoretical values for Ce as function of Ce*/Cp* and Cp (control of Ce by delivery and ICMRglc), undated
55	107	1383 conclusions, undated
55	108	1384 effects of chronic intraperitoneal administration of nitroarginine methyl ester (50mg/kg twice daily for 4 days) on increases in cerebral blood flow caused by breathing 5 percent C02, undated
55	109	1385 effect of intracisternal administration of nitroarginine methyl ester on nitric oxide synthase in brain, undated
55	110	1386 effect of chronic intraperitoneal administration of nitroarginine methyl ester on nitric oxide synthase in brain, undated
55	111	1387 [14C]iodoantipyrine autoradiographs of brain sections made from z-chloralose/urethane anesthetized rats [photographs, negative], undated
55	112	1388 [14C]deoxyglucose autoradiographs of brain sections from a rat whose vibrissae on the left side were continually stroked [photographs, negative], undated
55	113	1389 effects of inhibition of nitric oxide synthesis by intravenous administration of NG-metylarginine or NG-nitroarginine on arterial blood pC02 and pH, undated
55	114	1390 right-left differences in glucose utilization in primary motor (area 4) and premotor cortex (area 6) in unimanually active monkeys, undated
55	115	1391 right-left percent differences in glucose utilization in primary and secondary somatosensory cortex in unimanually active monkeys, undated
55	116	1392 effects of intravenous administration of NOS inhibitors on ICBF in whisker-to-barrel pathway during unilateral whisker stroking, undated
55	117	1393 effects of intracisternal administration of nitroarginine ME on ICBF in whisker-to-barrel pathway during unilateral whisker stroking, undated
55	118	1394 assay conditions for brain nitric oxide synthase activity, undated
55	119	1395 effects of intracisternal administration of artificial CSF and of nitroarginine on physiological variables in rats, undated
55	120	1396 effects of nitric oxide synthase inhibitors on increases in cerebral blood flow caused by breathing 5 percent C02, undated
55	121	1397 effect of unilateral whisker stroking on ICBF in whisker-to-barrel pathway (untreated rats), undated
55	122	1398 effects of 5 percent C02 in inspired air on arterial pC02 and pH in normal control rats and in rats administered inhibitors of nitric oxide synthase intravenously, undated
55	123	1399 effects of inhibition of nitric oxide synthesis by intravenous administration of NG-methylarginine or NG-nitroarginine on cerebral blood flow in conscious rats, undated
55	124	1400 [conscious vs. anesthetized glucose utilization [photographs, negative], undated
55	125	1401 relationships among glycolytic and oxidative rates of glucose utilization and ATP turnover, undated
55	126	1402 kinetic basis for obligatory increase in lactate/pyruvate concentrations during increases in oxidative glucose metabolism, undated
55	127	1403 relationship between oxygen and glucose metabolism in normal young adult human brain, undated
55	128	1404 cerebral blood flow and metabolic rate in humans with various disorders affecting mental state, undated
55	129	1406 relationship between cerebral oxygen consumption and glucose utilization in normal young adult man, undated
55	130	1407 energy metabolism per spike in dorsal horn, undated
55	131	1408 ICMRglc per spike in dorsal lumbar cord, undated
55	132	1431astrocytes -- intracellular products, undated
55	133	1432 astrocytes + MSO -- extracellular products, undated
55	134	1433 astrocytes + MSO -- intracellular products, undated
55	135	1434 astrocytes + neurons -- intracellular products, undated
55	136	1435 astrocytes + neurons + MSO -- intracellular products, undated
55	137	1436 astrocytes + neurons + MSO -- extracellular products, undated
55	138	1437 astrocytes + neurons -- extracellular products, undated
55	139	1438 astrocytes -- extracellular products, undated
55	140	1439 [14C]products (DPM), undated
55	141	1440 C02 fixation in primary CNS cultures, undated
55	142	1441 astroglia vs. neurons and astroglia, undated
55	143	1442 MIX-4: AAAnal IC and EC, undated
55	144	1443 K+ concentrations of astroglia and neurons, undated
55	145	1444 the effect of depolarizing agents on C02 fixation in astroglial cells, undated
55	146	1445 the effect of calcium on C02 fixation in astroglial cells, undated
55	147	1446 astroglia, fibroblasts, and neurons, undated
55	148	1447 [14C]deoxyglucose concentration, undated
55	149	1449 autoradiographic calibration [photographs, negatives], undated
55	150	1450 Aristotle quote, undated
55	151	1451 [14C]iodoantyiprine and [14C]deoxyglucose [photographs, negatives], undated
55	152	1452 glucose utilization during unilateral spreading depression in left hemisphere [photographs, negatives], undated
55	153	1453 percent activity newborn rat pup and 20 day rat pup [photographs, negatives], undated
55	154	1454 postnatal age activity [photographs, negatives], undated
55	155	1455 postnatal age activity [photographs, negatives], undated
55	156	1456 postnatal age activity [photographs, negatives], undated
55	157	1457 postnatal age and GHB and GABA concentrations [photographs, negatives], undated
55	158	1458 postnatal age and GHB concentration [photographs, negatives], undated
55	159	1459 postnatal age and activity [photographs, negative], undated
55	160	1460 apomorphine and ICMRglc [photographs, negative], undated
55	161	1461 [14C]iodoantipyrine autoradiographs of brain sections made from z-chloralose/urethane anesthetized rats [photographs, negative], undated
55	162	1462 [photographs, negative], undated
55	163	1463 blood pressure responses to stimulation during electrode placement under anesthesia [photographs, negative], undated
55	164	1464 unilateral and bilateral lesions [photographs, negative], undated
55	165	1465 blood pressure and biphasic stimulation [photographs, negative], undated
55	166	1466 varied blood pressure and biphasic stimulation [photographs, negative], undated
55	167	1467 blood pressure responses [photographs, negative], undated
55	168	1468 unilateral and bilateral lesions [photographs, negative], undated
55	169	1469 [14C]iodoantypyrine and [14C]deoxyglucose [photographs, negative], undated
55	170	1470 [photographs, negative], undated
55	171	1471 [photographs, negative], undated
55	172	1472 postnatal age and ICPSleu [photographs, negative], undated
55	173	1473 postnatal age and ICPSleu [photographs, negative], undated
55	174	1474 postnatal age and CPSleu[photographs, negative], undated
55	175	1475 effects of chronic intraperitoneal nitroarginine on baseline and on increases in blood flow due to unilateral whisker stroking in four stations of the whisker-to-barrel pathway [photographs, negative], undated
55	176	1476 effects of intracisternally infused artificial CSF or nitroarginine on baseline and increases in blood flow due to unilateral stroking of whiskers in four stations of the whisker-to-barrel pathway [photographs, negative], undated
55	177	1477 effects of intravenous nitroarginine on baseline and increases in blood flow in four stations of the whisker-to-barrel pathway due to unilateral stroking of whiskers [photographs, negative], undated
55	178	1478 table 1. Effects of various treatments with nitroarginine on nitric oxide synthase activity in rat brain [photographs, negative], undated
55	179	1481 effects of extracellular potassium ion concentration on phosphorylation of 2-deoxyglucose in cultured neurons and astroglia [title page?], undated
55	180	1482 assay protocol, undated
55	181	1483 standard reaction mixture, undated
55	182	1484 conclusions, undated
55	183	1485 effects of cultivation period on phosphorylation of [14C]2-deoxyglucose in astroglia, undated
55	184	1486 cell cultures, undated
55	185	1487 effects of extracellular potassium ion concentration on phosphorylation of [14C]2-deoxyglucose, undated
55	186	1488 effects of dibutyryl cyclic AMP on phosphorylation of [14C]2-deosyglucose in cultured astroglia, undated
55	187	1489 effects of cultivation period on phosphorylation of [14C]2-deoxyglucose in astroglia, undated
55	188	1490 effects of veratridine on phosphorylation of [14C]2-deoxyglucose, undated
55	189	1491 effects of extracellular potassium ion concentration on phosphorylation of [14C[-2-deoxyglucose, undated
55	190	1492 table 9. Cerebral blood flow and metabolic rate in humans with various disorders affecting mental state, undated
55	191	1493 table 4. Effects of insulin hypoglycemia on cerebral circulation and metabolism in humans, undated
55	192	1494 table 7. Effects of insulin in normoglycemia, insulin-induced hypoglycemia, and hyperglycemia on local cerebral glucose utilization in the rat, undated
55	193	1495 table 1. Effects of infusions of 2-deoxyglucose (500 mg/kg) on physiological variables, undated
55	194	1496 table 2. The effects of pharmacologic doses of 2-deoxyglucose (500 mg/kg) on local cerebral blood flow (ml/100 g/min), undated
55	195	1497 Ca standards and Ca standard curve [photographs, negative], undated
55	196	1498 Ca concentration gradients [photographs, negative], undated
55	197	1499 Frank and Ernest cartoon (1994), undated
55	198	1500 comic drawing of regions of the brain, undated
55	199	1501 plasma calcium concentrations and clearance of 45Ca from plasma, undated
55	200	1502 total calcium and integrated specific activity of 45Ca in arterial plasma as a function of age, undated
55	201	1503 total brain concentration, brain:plasma distribution ratios, apparent transfer coefficients, and net uptake of calcium into hand-dissected brain regions as a function of age, undated
55	202	1504 gradients of calcium transport in young, middle-aged, and old rats, undated
55	203	1505 rank order of regional uptake of calcium as a function of age, undated
55	204	1506 3-rate-constant (3K), 4-rate-constant (4K) model, and tissue heterogeneity (TH) model [negative], undated
55	205	1507 3K, 4K, and TH models [negative], undated
55	206	1508 3K model [negative], undated
55	207	1509 relationship between accumulated labeled and unlabeled lactate in cerebral cortex during spreading depression, undated
55	208	1510 3K, 4K, and TH models [negative], undated
55	209	1511 specific activities of lactate and glucose as functions of brain glucose level in activated (spreading depression) and control cerebral cortex, undated
55	210	1512 hypothetical reaction mechanism of enzymic NO formation, undated
55	211	1513 conscious and anesthetized glucose utilization, undated
55	212	1514 anonymous humorous quote, undated
55	213	1515 left-right (spreading depression vs. control) differences obtained with labeled deoxyglucose and glucose, undated
55	214	1516 brain:plasma distribution ratios for glucose (Ce/Cp) and [14C] deoxyglucose (Ce*/Cp*) and lambda (i.e., [Ce*/Cp*]/[Ce/Cp]) as functions of brain glucose content in warm- and cold-adapted, active control and hibernating squirrels, undated
55	215	1517 clearance of [14C]DG from squirrel plasma after an intravenous pulse, undated
55	216	1518 brain glucose level as a function of plasma glucose content in warm- and cold-adapted, active controls and hibernating squirrels, undated
55	217	1519 autoradiographic determination of concentrations of total 14C in activated (left) and control (right) cerebral cortex during unilateral KCL-induced activation of CMRglc, undated
55	218	1520 direct chemical assays of concentrations of glucose, [14C]precursor, and 14C-labeled metabolites and calculated rates of glucose utilization in cerebral cortex during KCL-induced activation of CMRglc at 5-7 min after the pulse of [14C]precursor, undated
55	219	1521 levels of glucose and [14C]deoxyglucose in plasma and several brain regions of active and hibernating squirrels at 45 min after a pulse of [14C]deoxyglucose, undated
55	220	1523 brain:plasma distribution ratios for glucose and [14C]deoxyglucose and estimated values for the factor lambda and the lumped constant of the operational equation of the [14C]deoxyglucose method for active and hibernating squirrels, undated
55	221	1524 separation of 14C-labeled metabolites derived from [6-14C]glucose in the control and activated cortex, undated
55	222	1525 physiological variables in active and hibernating ground squirrels, undated
55	223	1526 differences in metabolic rate with the mean rate of barrels A1-3 and E1-3 as reference, undated
55	224	1527 metabolic rates in left (L) and right ( R) barrel cortex [negative], undated
55	225	1528 effect of NO synthase inhibition on autoregulation [photographs, negative], undated
55	226	1529 effects of intravenous infusion of epinephrine on physiological variables and CBF, undated
55	227	1530 effects of glutamate on phosphorylation of [14C]2-deoxyglucose in cultured astroglia, undated
55	228	1531 effects of veratridine or monensin on phosphorylation of [14C]2-deoxyglucose in cultured astroglia, undated
55	229	1532 effects of veratridine on phosphorylation of [14C]2-deoxyglucose, undated
55	230	1533 effects of veratridine on phosphorylation of [14C]2-deoxyglucose in cultured neurons and astroglia, undated
55	231	1534 effects of dibutyryl cyclic AMP on phosphorylation of [14C]2-deoxyglucose in cultured astroglia, undated
55	232	1535 effects of extracellular potassium ion concentration on phosophrylation of [14C]2-deoxyglucose in different types of cultured cells, undated
55	233	1536 effects of chronic treatment with L-NAME on ICMRglc -- part 2, undated
55	234	1537 effects of chronic treatment with L-NAME on ICMRglc -- part 1, undated
55	235	1538 effect of NO synthase inhibition on autoregulation of CBF, undated
55	236	1539 effects of extracellular potassium ion concentration on phosphorylation of [14C]2-deoxyglucose in cultured astroglia, undated
55	237	1540 effects of cultivation period on phosphorylation of [14C]2-deoxyglucose in cultured astroglia, undated
55	238	1541 effects of chronic treatment with L-NAME on autoregulation of ICBF -- part 1, undated
55	239	1542 effects of chronic treatment with L-NAME on physiological variables, undated
55	240	1543 effects of chronic treatment with L-NAME on physiological variables measured just prior to the infusion of [14C]deoxyglucose, undated
55	241	1544 effects of chronic treatment with L-NAME on autoregulation of ICBF -- part 2, undated
55	242	1545 effects of insulin on physiological variables and CBF in euglycemic rats, undated
55	243	1546 effect of insulin-induced hypoglycemia on cerebral blood flow in conscious rats, undated
55	244	1547 effect of pharmacological doses of deoxyglucose on CBF in conscious rats, undated
55	245	1548 effect of insulin on cerebral blood flow in euglycemic rats, undated
55	246	1549 relationship between CBF and [K+] in insulin-induced htypoglycemia, undated
55	247	1550 relationship between arterial pH and CBF in insulin-induced hypoglycemia, undated
55	248	1551 relationship between plasma lactate and CBF in insulin-induced hypoglycemia, undated
55	249	1552 effects of insulin-induced hypoglycemia on physiological variables and CBF in the rat, undated
55	250	1553 effects of insulin-induced hypoglycemia on physiological variables and CBF in the rat, undated
55	251	1554 effects of NOS inhibitors on ICBF in whisker-to-barrel pathway during unilateral whisker stroking, undated
55	252	1555 arterial plasma valine concentration [photographs, negative], undated
55	253	1556 postnatal age and ICPSleu [photographs, negative], undated
55	254	1557 arterial plasma insulin level, arterial plasma glucose concentration, and arterial plasma valine concentration [photographs, negative], undated
55	255	1558 postnatal age and ICPSleu [photographs, negative], undated
55	256	1559 acute, chronic, and residual cocaine and saline vehicle [photographs, negative], undated
55	257	1560 behavioral scores and days of treatment for chronic vehicle and chronic cocaine [photographs, negative], undated
55	258	1561 postnatal age and CPSleu [photographs, negative], undated
55	259	1562 plasma, extracellular space, and intracellular space [photographs, negative], undated
55	260	1563 lesion of fastigial nucleus and autoregulation of CBF [photographs, negative], undated
55	261	1564 table 1. Physiological variables measured 45 seconds after starting stimulation and 15 seconds prior to the measurement of local cerebral blood flow or local cerebral glucose utilization, undated
55	262	1565 table 2. Effects of electrical stimulation of the left cerebellar fastigial nucleus on local cerebral blood flow, undated
55	263	1566 table 3. Effects of electrical stimulation of the left cerebellar fastigial nucleus on local cerebral glucose utilization, undated
55	264	1567 table 4. Effects of lesions of the cerebellar fastigial nucleus on physiological variables measured just before local cerebral blood flow measurement, undated
55	265	1568 table 5. Effects of left unilateral lesion of the cerebellar fastigial nucleus on local cerebral blood flow, undated
55	266	1569 table 6. Effects of lesions of the cerebellar fastigial nucleus on local cerebral blood flow, undated
55	267	1570 effects of insulin-induced hypoglycemia on physiological variables and CBF in the rat, undated
56	1	1571 table 3. Effects of increasing extracellular potassium ion concentration on rates of [14C]deoxyglucose phosphorylation in cultured astroglia [photographs, negative], undated
56	2	1572 table 2. Influ4ence of sodium pump activity and neurosecretion on [14C]deoxyglucose uptake in posterior pituitary in vitro, undated
56	3	1573 table 1. Representative values for local cerebral glucose utilization in normal conscious albino rat and monkey, undated
56	4	1574 change in [14C] DG phospohrylation (percentage), undated
56	5	1575 change in [14C] DG phospohrylation (percentage), undated
56	6	1576 effect of pharmacological dose of doexyglucose on cerebral blood flow, undated
56	7	1577 superior colliculus and lateral geniculate nucleus, undated
56	8	1578 veratridine and monensin [photographs, negative], undated
56	9	1579 neuronal, neuronal-astroglial, and astroglial extracellular potassium ion concentration [photographs, negative], undated
56	10	1580 [14C]deoxyglucose-6-phosphate with and without glutamate [photographs, negative], undated
56	11	1581 autoradiographic determination of concentrations of total 14C in activated (left) and control (right) cerebral cortex during unilateral KCL-induced activation of CMRglc, undated
56	12	1582 loss of labeled metabolites of [6-14C]glucose during bilateral spreading cortical depression, undated
56	13	1585 lactate loss from brain during bilateral spreading cortical depression+, undated
56	14	1587 transport of 14C-labeled lactate and inulin in brain during a 10 min interval, undated
56	15	1590 Ce*/Cp* as function of Ce at Cp = 5.6 mM, undated
56	16	1591 combined experimental results: Ce*/Cp* as function of Ce when Ce is varied mainly by delivery or by the rate of glucose utilization, undated
56	17	1592 nucleus accumbens and sensory motor cortex, undated
56	18	1593 caudate-putamen and globus pallidus, undated
56	19	1594 ventral N. thalamus and internal capsule, undated
56	20	1595 average whole brain CBF and insulin-treated euglycemic, undated
56	21	1596 average whole brain CBF with saline + DG and L-NAME + DG, undated
56	22	1597 average whole brain CBF and arterial plasma glucose concentration (mM), undated
56	23	1598 average whole brain CBF and arterial plasma glucose concentration (mM), undated
56	24	1599 table 1. Effects of insulin on physiological variables measured just before CBF measurement, undated
56	25	1600 table 2. Effects of insulin on physiological rats variables in euglycemic rats, undated
56	26	1601 table 3. Effects of pharmacological doses of DG on physiological variables and CBF, undated
56	27	1602 table 4. Effects of chronic treatment with L-NAME on physiological variables in insulin-treated rats, undated
56	28	1603 table 5. Effects of 2-DG and chronic treatment with L-NAME on physiological variables measured just before CBF measurement, undated
56	29	1605 effects of insulin on physiological variables measured just before CBF measurement, undated
56	30	1606 effects of insulin on physiological variables in euglycemic rats, undated
56	31	1607 effects of pharmacological doses of DG on physiological variables and CBF, undated
56	32	1608 effects of 2-DG and chronic treatment with L-NAME on physiological variables measured just before CBF measurement, undated
56	33	1609 effects of chronic treatment with L-NAME on physiological variables in insulin-treated rats, undated
56	34	1610 table 2. Effects of inhibitors of nitric oxide synthase on physiological variables during inhalation of room air or 5 percent C02, undated
56	35	1612 distribution of [U-14C]lactate and its metabolites in brains of anesthetized rats at 10 min after an intracerebral injection, undated
56	36	1613 effect of chronic intraperitoneal administration of nitroarginine on CBF and on increases in CBF produced by 5 percent C02, undated
56	37	1614 conclusions, undated
56	38	1619 newborn astroglia, undated
56	39	1620 extracellular and intracellular astroglia and neurons, undated
56	40	1640 effects of intravenous infusions of epiephrine on cerebral glucose utilization, undated
56	41	1641 effects of intravenous infusions of epinephrine on cerebral blood flow, undated
56	42	1642 effects of caffeine on CBF enhancement by insulin-induced hypoglycemia, undated
56	43	1643 effects of glibenclamide on CBF enhancement by insulin-induced hypoglycemia, undated
56	44	1644 CBF as a function of plasma glucose concentration, undated
56	45	1645 CBF as a function of plasma glucose concentration, undated
56	46	1646 CBF as a function of plasma glucose concentration, undated
56	47	1647 CBF as a function of arterial glucose concentration, undated
56	48	1648 CBF vs plasma glucose concentration in insulin-treated rats without and after pretreatment with nitroarginine, undated
56	49	1649 effect of insulin on CBF in euglycemic rats, undated
56	50	1650 arterial plasma glucose and catecholamines induced by glucoprivation due to insulin administration or pharmacological doses of deoxyglucose, undated
56	51	1651 effects of acute and chronic nitroarginine pretreatment on CBF enhancement by pharmacological doses of 2-deoxyglucose, undated
56	52	1652 effects of acute and chronic nitroarginine pretreatment on CBF enhancement by insulin-induced hypogylcemia, undated
56	53	1653 [14C]deoxyglucose-6-phosphate and glutamate [photographs], undated
56	54	1654 effects of insulin on physiological variables in euglycemic rats, undated
56	55	1655 diffusion-equilibrium blood flow model, undated
56	56	1657 effects of caffeine on local cerebral blood flow during functional activation of whisker-barrel pathway, undated
56	57	1658 calculated and measured methylglucose distribution ratio, undated
56	58	1659 calculated and measured brain glucose content, undated
56	59	1660 control of brain glucose level mainly by supply (constant demand), undated
56	60	1661 control of brain glucose level mainly by demand (constant supply), undated
56	61	1662 table 2. Influences of bicuculline and muscimol on rate of glucose utilization and methylglucose brain:plasma distribution ratio, undated
56	62	1663 table 1. Physiological variables in animals studied with topical applications of bicuculline or muscimol, undated
56	63	1664 diffusion-equilibrium blood flow model, undated
56	64	1665 average whole brain CBF and glibenclamide, undated
56	65	1666 average whole brain CBF and caffeine, undated
56	66	1667 concluding remarks, undated
56	67	1668 cerebral circulation and metabolism during deep sleep, undated
56	68	1669 local cerebral glucose utilization in non-rapid eye movement sleep in monkeys, undated
56	69	1670 cerebral circulation and metabolism during sleep and mental 'work', undated
56	70	1671 cerebral circulation and metabolism in schizophrenia and LSD-induced psychotomimetic state, undated
56	71	1672, undated
56	72	1673 rates of leucine incorporation and weighted percentage time in deep sleep, undated
56	73	1674 effects of catecholamines on cerebral circulation and metabolism, undated
56	74	1675 protein synthesis in deep sleep, undated
56	75	1676 table II. Cerebral nutritional insufficiency and mental state, undated
56	76	1677 table IV. Cerebral circulation and metabolism in normal aging, arteriosclerosis and chronic brain syndrome, undated
56	77	1679 hyperpolarization, relaxation, and vasodilation, undated
56	78	1680 table 2. Relationship between oxygen and glucose metabolism in normal young adult human brain, undated
56	79	1681 table 1. Substances utilized or produced by normal young adult human brain, undated
56	80	1682 relationships among glycotic and oxidative rates of glucose utilization and ATP turnover in normal conscious human brain, undated
56	81	1683 energy metabolism per spike, undated
56	82	1684 energy metabolism per Hz, undated
56	83	1686 table II Substrates of cerebral energy metabolism in human adults during prolonged starvation, undated
56	84	1687 molecular layer of hippocampus, undated
56	85	1688 cerebral blood flow, undated
56	86	1689 table 2. Metabolite levels in cerebral cortex before, during and following sensory stimulation, undated
56	87	1690 table 1. Physiological variables and arteriovenous differences just prior to in situ freezing, undated
56	88	1691 spinal trigeminal nucleus, principal sensory trigeminal nucleus, VPM thalamic nucleus, and somatosensory cortex, barrel field [negatives], undated
56	89	1692 cerebral blood flow [negatives], undated
56	90	1693 table 1. Effects of scopolamine on physiological variables, undated
56	91	1694 C. S. Roy and C. S. Sherrington quote, undated
56	92	1695 C. S. Roy and C. S. Sherrington quote, undated
56	93	1696 average whole brain CBF and caffeine and glibenclamide, undated
56	94	1697 average whole brain CBF and arterial plasma glucose concentration, undated
56	95	1698 table 1. Effects of insulin-induced hypoglycemia, insulin administration under euglycemic conditions, and pharmacologic doses of 2-deoxyglucose on blood constituents and global cerebral blood flow, undated
56	96	1699 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, and somatosensory cortex barrel field, undated
56	97	1700 cerebellar white matter, caudate-putamen, primary motor cortex, and accumbens nucleus core, undated
56	98	1701 table 2. Effects of insulin-induced bypoglycemia and pharmacological doses of 2-doexyglucose on adenosine, inosine, and hypoaxanthine levels in conscious rat brain, undated
56	99	1702 weighted average whole brain blood flow and epinephrine, undated
56	100	1703 table 1. Physiological variables and arteriovenous differences just prior to in situ freezing, undated
56	101	1704 resources -- Louis Sokoloff, M.D. -- Laboratory of Cerebral Metabolism, undated
56	102	1705 table 2. Metabolite levels in cerebral cortex before, during and following sensory stimulation, undated
56	103	1707 resources -- Louis Sokoloff, M.D. -- Laboratory of Cerebral Metabolism, undated
56	104	1708 compartmental models that do not meet the conditions for application of spectral analysis to total tissue activity, undated
56	105	1709 compartmental models that satisfy the conditions for application of spectral analysis to total tissue activity, undated
56	106	1710 compartmental systems formed by removing a link from a strongly connected noncyclic system, undated
56	107	1711 construction of the sign-symmetric completion of a compartmental system, undated
56	108	1712 strongly connected noncyclic compartmental systems, undated
56	109	1713 residual intracellular 2-[14C]DG-6-P after extended incubation, undated
56	110	1714 [14C] glucose standard, zero time, 5 minute incubation, 10 minute incubation, and 15 minute incubation, undated
56	111	1715 phosphorylation reaction and phosphatase activity, undated
56	112	1716 time course of 3H/14C ratio during incubation of astroglia with [2-3H]Glucose and [U-14C]glucose, undated
56	113	1717 residual intracellular 2-[14C]DG-6-P after extended incubation, undated
56	114	1718 active and hibernating effluent volumes, undated
56	115	1719 ribosomes and [3H]-leucine incorporation, undated
56	116	1720 active and hibernating [3H]-leucine incorporation, undated
56	117	1721 molecular mechanisms in physiological regulation of cerebral blod flow and metabolism [title page?], undated
56	118	1722 background, undated
56	119	1723 effects of insulin-induced hypoglycemia, insulin administration under euglycemic conditions, and opharmacologic doses of 2-deoxyglucose on systemic physiological variables that might influence cerebral blood flow, undated
56	120	1724 effects of insulin-induced hypoglycemia, insulin administratio nunder euglycemic conditions and pharmacologic doses of 2-deoxyglucose on blood constituents and global cerebral blood flow, undated
56	121	1725 recent and current research, undated
56	122	1726 conclusions, undated
56	123	1728 active and hibernating [3H]-leucine incorporation, undated
56	124	1729 intracellular 14C DPM and 3H DPM distances from origin, undated
56	125	1730 intracellular and extracellular 14C DPM per [symbol]g protein, undated
56	126	1731 intracellular 14C DPM distances from origin, undated
56	127	1732 intracellular and extracellular 14C DPM per [symbol]g protein, undated
56	128	1733 table3. Relationship between cerebral oxygen consumption and glucose utilization in a normal young adult man, undated
56	129	1734 intracellular [2-3H-glucose / [U-14C]glucose ratio incubation time, undated
56	130	1735 intracellular [2-3H-glucose / [U-14C]glucose ratio incubation time, undated
56	131	1736 intracellular and extracellular 14C DPM per [symbol]g protein, undated
56	132	1737 intracellular 14C DPM distances from origin, undated
56	133	1738 extracellular 14C DPM distances from origin, undated
56	134	1739 intracellular and extracellular 14C DPM per [symbol]g protein, undated
56	135	1740 intracellular [2-3H-glucose / [U-14C]glucose ratio incubation time, undated
56	136	1741 intracellular 14C DPM and 3H DPM distances from origin, undated
56	137	1742 table 1. Physiological variables immediately before measurement of cerebral blood flow, undated
56	138	1743 table 2. Effects of caffeine on CBF during sitmulation of vibrissae on left side of face in structures outside whisker-barrel pathway, undated
56	139	1744 table 3. Effects of caffeine on activation of local cerebral glucose utilization (ICMRglc) by vibrissal stimulation in whisker-to-barrel cortex sensory pathway, undated
56	140	1745 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, barrel field of sensory cortex, undated
56	141	1746 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, barrel field of sensory cortex, undated
56	142	1747 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, barrel field of sensory cortex, undated
56	143	1748 intracellular 14C DPM and 3H DPM distances from origin, undated
56	144	1749 intracellular and extracellular 14C DPM per [symbol]g protein, undated
56	145-148	1750-1753 extracellular 14C DPM distances from origin, undated
56	149	1754 time courses of intracellular and extracellular 14C contents -- standard assay conditions, undated
56	150	1755 extracellular 14C DPM distances from origin, undated
56	151	1756 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, barrel field of sensory cortex, undated
56	152	1757 table 1. Physiological variables immediately before measurement of cerebral blood flow, undated
56	153	1758 diffusion-equilibrium blood flow model, undated
56	154	1759 table 1. The effect of extracellular potassium concentration on lactate formation in astroglial cells in culture, undated
56	155	1760 table 2. The effect of extracellular potassium on C02 fixation and on lactate formation in astroglial cells in culture, undated
56	156	1761 table 3. Products formed by astroglial cells incubated with 14C-labeled bicarbonate: the effect of increased extracellular potassium, undated
56	157	1762 table 4. Glucose utilization in cells in culture, undated
56	158	1763 table 5. The effect of L-lactate on the oxidation of D-Glucose (2.5mM) to C02, undated
56	159	1764 table 6. The effect of D-Glucose on the oxidation of L-lactate (2mM) to C02, undated
56	160	1765 Ce*/Cp* as function of Ce at Cp = 6.8 mM, undated
56	161	1766 Ce/Cp* as function of Ce at Cp = 4.5 mM, undated
56	162	1767 frequency of stimulation of glucose utilization [photographs, negative], undated
56	163	1768 functioal plasticity in barrel cortex after depression, undated
56	164	1769 combined theoretical values for Ce as function of Ce*/Cp* and Cp (control of Ce by delivery and CMRglc), undated
56	165	1770 selective trapping of 45Ca during metabolic activation [photograph], undated
56	166	1771 selective trapping of 45Ca during metabolic activation [photograph], undated
56	167	1772 effect of unilateral visual stimulation on glucose utilization, effect of visual stimulation on the increase in glucose utilization in superior colliculus, relative increase in glucose utilization in stimulated superior colliculus, undated
56	168	1773 table 1. Influence of sodium pump activity and neurosecretion on [14C]deoxyglucose uptake in posterior pituitary in vitro, undated
56	169	1774 diagram of veins and sinuses of the human brain [photograph], undated
60	1	071053 -- autoradiographs, undated
60	2	071753A -- RA9 [photograph, negative], undated
60	3	071753A -- 10 [photograph, negative], undated
60	4	071753A -- 17 [photograph, negative], undated
60	5	071753A -- 26 [photograph, negative], undated
60	6	071753A -- RA27 [photograph, negative], undated
60	7	071753A -- RA29 [photograph, negative], undated
60	8	071753B [photographs, negatives], undated
60	9	072453A #1 [photograph, negative], undated
60	10	072453A #2 [photograph, negative], undated
60	11	072453A #3 [photograph, negative], undated
60	12	072453A #5 [photograph, negative], undated
60	13	072453A [photograph, negative], undated
60	14	072453A [photograph, negative], undated
60	15	072453A [photograph, negative], undated
60	16	072453B -- no densitometry [photograph, negative], undated
60	17	072453B #4 RA6 [negative], undated
60	18	073053A #1 [photograph, negative], undated
60	19	073053A #2 [photograph, negative], undated
60	20	073053A #3 [photograph, negative], undated
60	21	073053A #5 [photograph, negative], undated
60	22	073053A #6 [photograph, negative], undated
60	23	073053A #7 [photograph, negative], undated
60	24	073053A #8 [photograph, negative], undated
60	25	073053B -- 9 [photograph, negative], undated
60	26	073053B -- 10 [photograph, negative], undated
60	27	073053B -- 11 [photograph, negative], undated
60	28	073053B -- 12 [photograph, negative], undated
60	29	073053B -- 13 [photograph, negative], undated
60	30	073053B -- 14 [photograph, negative], undated
60	31	073053B -- 15 [photograph, negative], undated
60	32	073053B -- 16 [photograph, negative], undated
60	33	080653A -- AR17 [photograph, negative], undated
60	34	080653A -- AR18 [photograph, negative], undated
60	35	080653A -- AR19 [photograph, negative], undated
60	36	080653A -- AR20 [photograph, negative], undated
60	37	080653A -- AR21 [photograph, negative], undated
60	38	080653A -- AR22 [photograph, negative], undated
60	39	080653A -- AR23 [photograph, negative], undated
60	40	080653A -- AR24 [photograph, negative], undated
60	41	080653A -- AR25 [photograph, negative], undated
60	42	080653A -- AR26 [photograph, negative], undated
60	43	080653A -- AR27 [negative], undated
60	44	080653A -- AR28 [photograph, negative], undated
60	45	080653A -- AR29 [photograph, negative], undated
60	46	080653B [photographs, negatives], undated
60	47	081353 [negatives], undated
60	48	5613001 -- cat 40s-10 [negative], undated
60	49	5613002 -- 3 C02-10 [negative], undated
60	50	5613003 -- 5 C02-10 [negative], undated
60	51	5613004 -- 3 02-10 [negative], undated
60	52	5613005 -- 2 C02-10 [negative], undated
60	53	5613006 -- CT6 C02-10 [negative], undated
60	54	5613007 -- 6 C02-10; 4 02-10 [negative], undated
60	55	5613008 -- 4 C0-10 [negative], undated
60	56	564102 [negative], undated
60	57	564103 [negative], undated
60	58	564104 [negative], undated
60	59	564105 [negative], undated
60	60	564106 [negative], undated
60	61	564101 [negative], undated
		Cat, 1953-1957, undated [subseries]:
60	62	5612701 -- cat 5 W2-5 [negative], undated
60	63	5612702 -- cat SCL 2 [negative], undated
60	64	5612703 -- cat SCL 4 [negative], undated
60	65	5612704 -- cat 102-10 [negative], undated
60	66	5612705 -- cat SCL 8 [negative], undated
60	67	5612706 -- cat SCL 15 [negative], undated
60	68	5612707 -- cat 202-10 [negative], undated
60	69	5612708 -- cat 1 C02-5 [negative], undated
60	70	5612709 -- cat SCL 6 [negative], undated
60	71	5612710 -- cat SCL 3 [negative], undated
60	72	5612711 -- cat SCL 4 [negative], undated
60	73	5612712 -- cat 1 C02-10 [negative], undated
60	74	5612713 -- control cat 2 02-10, 1 C02-10 [negative], undated
60	75	5612714 -- cat 4 C02-5 [negative], undated
60	76	5612715 -- cat 5 SCL [negative], undated
60	77	5612716 -- cat 2 C02-5 [negative], undated
60	78	5612717 -- cat 14 SCL [negative], undated
60	79	5612718 -- cat 3 C02-5 [negative], undated
60	80	5612719 -- cat 13 SCL [negative], undated
60	81	5612720 -- cat SCL 12 [negative], undated
60	82	5612721 -- cat SCL 1 [negative], undated
60	83	5612722 -- cat 6 C02-5 [negative], undated
60	84	Cat no. 1 -- [negatives], 12/3/1953
60	85	Cat no. 2 [negatives], undated
60	86	Cat no. 3 -- [negatives], 12/17/1953
60	87	Cat no. 4 -- [negatives], 12/17/1953
60	88	Cat no. 5 -- [negatives], 1/7/1954
60	89	Cat no. 6 -- [negatives], 1/7/1954
60	90	Cat no. 7 -- [negatives], 1/14/1954
60	91	Cat no. 7 and 8 -- heart and kidney [negatives], undated
60	92	Cat no. 8 -- [negatives], 1/14/1954
60	93	Cat no. 9 -- [negatives], 2/4/1954
60	94	Cat no. 10 -- [negatives], 2/4/1954
60	95	Cat no. 11 -- [negatives], 2/11/1954
60	96	Cat no. 12 -- [negatives], 2/11/1954
60	97	Cat no. 13 -- saturation (#2 and 22 taken 5/21/57) [negatives], 2/12/1954; 5/21/1957
60	98	Cat no. 14 -- saturation (#9 taken 5/21/57) [negatives], 2/12/1954; 5/21/1957
60	99	Cat no. 15 -- cochlea destroyed [negatives], 2/25/1954
60	100	Cat no. 16 -- cochlea destroyed [negatives], 2/25/1954
60	101	Cat no. 17 -- cochlea destroyed [negatives], 3/4/1954
60	102	Cat no. 18 -- cochlea destroyed [negatives], 3/4/1954
60	103	Cat no. 19 -- [negatives], 5/20/1954
60	104	Cat no. 20 -- [negatives], 5/20/1954
60	105	Cat no. 21 -- lambda [negatives], 5/29/1954
60	106	Cat no. 23 -- [negatives], 6/3/1954
60	107	Cat no. 23 -- lambda [negatives], 6/3/1954
60	108	Cat no. 24 - (#11 and 16 in slides) [negatives], 6/3/1954
60	109	Cat no. 25 -- repeat (air exposure) [negatives], 6/9/1954
60	110	Cat no. 26 -- [negatives], 6/9/1954
60	111	Cat no. 26 -- reput [negatives], 6/9/1954
60	112	Cat no. 27 [negatives], 6/17/1954
60	113	Cat no. 28 [negatives], 6/17/1954
60	114	Cat no. 29 [negatives], 6/24/1954
60	115	Cat no. 30 [negatives], 6/24/1954
60	116	Cat no. 31 -- films 41, 45, 49 taken for England [negatives], 7/1/1954
60	117	Cat no. 32 [negatives], 7/1/1954
60	118	Cat no. 33 [negatives], 7/8/1954
60	119	Cat no. 34 -- for illustrations #17 and 20 in slides [negatives], 7/18/1954
60	120	Cat no. 35 -- lampda [negatives], 6/9/1954
60	121	Cat no. 35 -- [negatives], 7/15/1954
60	122	Cat no. 36 -- (#45 to England) [negatives], 7/15/1954
58	1	Cat 1 02 10 [negatives], undated
58	2	Cat 2 02-10 [negatives], undated
58	3	Cat 2 02-10 control for 2 02-10, 1C02-10 [negatives], undated
58	4	Cat 3 02-10 -- fig. 1A [negatives], undated
58	5	Cat 4 02-10 [negatives], undated
58	6	Control for Cat 4 02-10 and 6 C02-10 [negatives], undated
58	7	Cat 5 02-10 -- control 10 C02 5 [negatives], undated
58	8	Cat 6 02-10 [negatives], undated
58	9	Cat 7 02-10 [negatives], undated
58	10	Cat 1 02-100 [negatives], 5/14/1957
58	11	Cat 2 02-100 [negatives], undated
58	12	Cat 3 02-100 [negatives], undated
58	13	Cat 5 02-100 [negatives], undated
58	14	Cat 6 02-100 [negatives], undated
58	15	Cat 7 02-100 (control) [negatives], undated
58	16	Cat 8 02-100 [negatives], undated
58	17	Cat 9 02-100 [negatives], undated
58	18	Cat 10 02-100 [negatives], undated
58	19	Cat 1 C02-5 -- used #20 for slide for fed. meet [negatives], 4/15/1957
58	20	Cat 2 C02-5 [negatives], 9/26/1956
58	21	Cat 3 C02-5 [negatives], undated
58	22	Cat 4 C02-5 [negatives], undated
58	23	Cat 5 C02-5 [negatives], undated
58	24	Cat 5 C02-5 -- film too dark, other film of this cat more acceptable [negatives], undated
58	25	Cat 6 C02-5 [negatives], undated
58	26	Cat 7 C02-5 [negatives], undated
58	27	Cat 8 C02-5 [negatives], undated
58	28	Cat 9 C02-5 [negatives], undated
58	29	Cat 10 C02-5 [negatives], undated
58	30	Cat 11 C02-5 [negatives], undated
58	31	Cat 12 C02-5 [negatives], undated
58	32	Cat 13 C02-5 [negatives], undated
58	33	Cat 14 C02-5 [negatives], undated
58	34	Cat 15 C02-5 [negatives], undated
58	35	Cat 16 C02-5 [negatives], undated
58	36	Cat 17 C02-5 [negatives], 5/14/1957
58	37	Cat 1 C02-10 -- film 27 used for England, used film 28 for slide fed meet [negatives], 4/15/1957
58	38	Cat 2 C02-10 -- make darkest -- fig 1C [negatives], undated
58	39	Cat 3 C02-10 [negatives], undated
58	40	Cat 4 C02-10 [negatives], undated
58	41	Cat 5 C02-10 -- fig 1B [negatives], undated
60	123	Cat 1 SCL -- unstimulated control (#8 to England) [negatives], 5/8/1956
60	124	Cat 2 SCL -- 5' retinal stimulation (#19 and 21 to England) [negatives], 5/8/1956
60	125	Cat 3 SCL -- stimulated cat [negatives], 5/11/1956
60	126	Cat 4 SCL -- unstimulated cat (#20 to England) [negatives], 5/11/1956
60	127	Cat 5 SCL -- stimulated [negatives], 5/24/1956
60	128	Cat 6 SCL [negatives], 5/24/1956
60	129	Cat 7 SCL -- control [negatives], 7/3/1956
60	130	Cat 8 SCL -- 5' retinal stimulation [negatives], 7/3/1956
60	131	Cat 9 SCL -- stimulated 10' [negatives], 7/26/1956
60	132	Cat 11 SCL -- 10 minutes stimulation [negatives], 7/30/1956
60	133	Cat 12 SCL -- 5' retinal stimulation [negatives], 9/11/1956
60	134	Cat 13 SCL -- control for 5 stimulation (note: film #24 not used) [negatives], 9/11/1956
58	42	Cat 1-SCLN (too dark to use) [negatives], undated
58	43	Cat 3-SCLN [negatives], undated
59	1	Cat 1ON -- stimulated optic nerve [negatives], 1/26/1956
59	2	Cat 2ON -- optic nerve crushed [negatives], 1/26/1956
59	3	Cat 1P -- pentothal -- #8 to slide [negatives], 12/16/1954
59	4	Cat 2 -- pentothal [negatives], 12/23/1954
59	5	Cat 3P -- cat 3 pentothal [negatives], 12/30/1954
59	6	Cat 4P -- pentothal [negatives], 12/30/1954
59	7	Cat 5P -- pentothal cat [negatives], 1/6/1955
59	8	Cat 6P -- pentothal cat [negatives], 1/6/1955
59	9	Cat 7P -- pentothal [negatives], 1/13/1955
59	10	Cat 8P -- pentothal [negatives], 1/13/1955
59	11	Cat 11P -- pentothal [negatives], 2/4/1955
59	12	Cat 12P -- pentothal [negatives], 2/4/1955
59	13	Cat 13P [negatives], 2/7/1955
59	14	Cat 14P [negatives], 2/17/1955
59	15	Cat 1PS -- film series a" [negatives]", 5/11/1955
59	16	Cat 1PS [negatives], 5/11/1955
59	17	Cat 2PS -- film series "a" [negatives], 5/11/1955
59	18	Cat 2PS [negatives], 5/11/1955
59	19	Cat 3PS [negatives], 5/12/1955
59	20	Cat 4PS [negatives], 5/12/1955
59	21	Cat 5PS -- negative #3 and 6 -- make into slides [negatives], 5/13/1955
59	22	Cat 1V (films 23 and 24 out of order) [negatives], 10/20/1955
59	23	Cat 2V -- (films 21 and 22 were out of order) [negatives], 10/20/1955
59	24	Cat 3V [negatives], 10/24/1955
59	25	Cat 4V [negatives], 10/24/1955
59	26	Cat 5V [negatives], 10/26/1955
59	27	Cat 5V [negatives], 10/26/1955
59	28	Cat 6V -- lost tissue section [negatives], 10/26/1955
59	29	Cat 7V -- films too light [negatives], 11/16/1955
59	30	Cat 7V -- films "A" repeat [negatives], 11/16/1955
59	31	Cat 8V [negatives], 11/16/1955
59	32	Cat 9V [negatives], 11/17/1955
59	33	Cat 10V [negatives], 11/17/1955
59	34	Cat 11V [negatives], 11/23/1955
59	35	Cat 12V [negatives], 11/23/1955
59	36	Cat 1VP -- film 18 not used [negatives], 11/19/1955
59	37	Cat 2VP [negatives], 11/19/1955
59	38	Cat 3VP -- not stimulated visually [negatives], 11/20/1955
59	39	Cat 3VP and Cat 4VP -- visually stimulated [negatives], 11/20/1955
59	40	Cat L1(a) [negatives], 7/7/1955
59	41	Cat L1 [negatives], 7/7/1955
59	42	Cat L2 [negatives], 7/7/1955
59	43	Cat L4 [negatives], 7/16/1955
59	44	Cat L5 [negatives], 7/12/1955
59	45	Cat L6 -- "Lou" [negatives], undated
59	46	Cat L7 [negatives], 7/28/1955
59	47	Cat L8 [negatives], 7/28/1955
		P [subseries]:
56	170	P 107 diazepam vs. control [photographs], undated
56	171	P 108 D and M lesion vs. control [photograph], undated
56	172	P 109 morphine vs. control [photographs], undated
56	173	P 110 LBH lesion vs. control [photographs], undated
56	174	P 163 arumd (Kennedy) [photographs], undated
56	175	P 192 thiopental rat [photographs], undated
		SM [subseries]:
56	176	SM-3 [photographs], undated
56	177	SM-6 (both eyes patched) [photographs, negatives], undated
56	178	SM-12 [photographs], undated
56	179	SM-13 left eye enucleation [photograph], undated
56	180	SM-14 [photograph], undated
56	181	SM-21, undated
56	182	SM-21 rt. eye enucleation [photographs, negative], undated
56	183	SM-23 control [photographs, negatives], undated
56	184	SM-25 [photographs], undated
56	185	SM-26 eye patched [photographs, negative], undated
56	186	SM-27 [photographs, negative], undated
56	187	SM-28 long term monocular occlusion [photographs, negative], undated
56	188	SM-29 [photographs, negative], undated
56	189	SM-33 [photographs, negative], undated
56	190	SMII -- both eyes open before rotatory screen [photographs, negatives], undated
		Unnumbered, 1954-1988 [subseries]:
56	191	Unidentified negatives [photographs, negative], undated
60	135	[unidentified] [negatives], undated
60	136	[unidentified] [negatives], undated
56	192	A/V DG plasma concentration in cat [photographs], undated
56	193	ARC 146A Stds. (OMI film), 1985-1986
56	194	Blood flow in anesthetized rats [photographs, negatives], undated
136	22	Buhda Films, undated
56	195	CBF and CMR 02 [photographs, negatives], undated
56	196	CBF and CMR 02 [photographs, negatives], undated
56	197	Circulatory system of the human head [photographs, negative], undated
56	198	Cocaine [photograph], undated
56	199	Crop [photographs, negative], undated
60	137	Densitometric calibration control -- 9 stds [negative], 6/18/1954
56	200	Derivation of Patlak plot [photographs], undated
56	201	Effect of morphine on glucose utilization [photographs], undated
56	202	Effective rate constant vs. time [photographs, negative], undated
56	203	Electrophoretic patterns of purified HMBP's [photographs, negatives], undated
56	204	Exposure [negative], 1988
58	44	1st attempt to judge if the krypton 85 diffuses out of std with sawing -- too dark, probably not [negatives], undated
58	45	2nd attempt to judge if Kr85 diffuses from head with sawing -- not as can be determined [negatives], undated
56	205	Human central anterior circulation [photographs, negative], undated
56	206	Hypophysis [photographs], undated
56	207	Hypothalamus (insulin effect on LGU) [photographs, slide], undated
56	208	Joke: May be on to something. . ." [negative]", undated
56	209	LCBF [photographs, negatives], 1971
56	210	LCBF in mice [photographs, negatives], undated
56	211	LCGU in sup. collic. and lateral geniculate nucleus [photographs, negative], undated
56	212	Lateral surface of the macaque brain [negatives], undated
56	213	Leg blood flow metabolism [photographs, negatives], undated
56	214	Locus coeruleus [photographs], undated
56	215	MEG of rat L + R enucleation -- sup. col. only -- test photos [negatives], undated
60	138	Materials for slides, undated
56	216	Methods fig. [photographs, negatives], undated
56	217	Misc. [negatives], undated
56	218	Model and operational equation for equilibrium method for the determination of local cerebral blood flow, undated
56	219	Monkey not working [photographs], undated
56	220	Monkey put. in Parkinsonism [photographs, negative], undated
56	221	Monkey using lt. arm suppl. motor ctx. [photographs], undated
56	222	Motor cortex [photographs, negative], undated
56	223	Moving lt. arm and inactive [photographs, negative], undated
59	48	Name -- Seymour [negatives], undated
59	49	Name -- Lou [negatives], undated
59	50	Name -- Bill [negatives], undated
59	51	Name -- Bud [negatives], undated
59	52	Name -- Walt [negatives], undated
59	53	Name -- Darob [negatives], undated
59	54	Name -- Mary [negatives], undated
59	55	Name -- Bob [negatives], undated
56	224	Newborn 101, long term patching, 1976-1977
56	225	Newborn (NBM 2) eye patched [photographs, negative], undated
56	226	Newborn (NBM 5) control [photographs, negative], undated
56	227	Newborn (NBM-6) control [photographs, negative], undated
56	228	Newborn (NBM-I) control [photographs, negative], undated
56	229	Newborn puppies. antipyrine -- blood flow [photographs], undated
56	230	Nose -- photos [photographs], undated
57	1	Operational equation [photographs], undated
57	2	Parkinsonian syndrome [photographs, negatives], undated
57	3	Percentage dephosphorylation of [14C] DG-6-P at time F [photographs, negatives], undated
57	4	Phosphate [photographs, negative], undated
57	5	Postmortem changes in DG and metabolites [photographs, negative], undated
57	6	Rat -- normal controls -- LCGU [photographs], undated
57	7	Rat auditory structures LCGO, undated
57	8	Rat visual structure LCGU, enucleation [photograph], undated
57	9	Sciatic n. stimu. and DRG [photographs], undated
57	10	Subfornical organ [photograph, slide], undated
57	11	Subfornical organ vs. saline, A 11 and saralasin A11 [photograph], undated
57	12	Sugar [photographs], undated
57	13	T 86 changes in metabolic activity following stimu. of the ventral, undated
136	23	Tattoo Films, undated
57	14	Thiomin section -- rat spinal cord [photographs], undated
57	15	Windy -- photos [photographs, negative], undated
57	16	Wortz geometric design [photographs], undated
58	46	X-sympathetic stim. [negatives], undated
		Autoradiographs, 1970-2002 [subseries]:
61		Standards C14, Cold Brain, Puppy Lambda, Equilibrium study [48 autoradiographs], 1970-1985
61		Cat-1 and Cat-3 [19 autoradiographs], 1971
61		CBF Cat-1 through CBF Cat-6 [38 autoradiographs], 1971
61		EC-1 [1 autoradiograph], 1971
61		Rat X-2 [1 autoradiograph, 1971
61		C-1 through C-2 [3 autoradiographs], 1973
61		DG-101 through DG-122; HR-201 [29 autoradiographs], 1973, 1976
61		DG-201A through DG-216A -- experiment documentation, 1973
61		DG-201A through DG-216A [19 autoradiographs], 1973
61		DGH3-test and DGH3-1 [4 autoradiographs], 1973
61		MG-5-6, 8-9, 12, 14-16 [8 autoradiographs], 1973
61		MG-101 through MG-114 [14 autoradiographs], 1973
61		MG-1-4, 7, 10, 13, 17, 18; Methyl glucose 10 minutes [10 autoradiographs], 1973, 1977
61		SC1 and SC1A [23 autoradiographs], 1973
61		SM-2 [stimulated squirrel monkey] [23 autoradiographs], 1973
61		SM-2A [stimulated squirrel monkey] [10 autoradiographs], 1973
61		SM-3 [stimulated rhesus monkey] [11 autoradiographs], 1973
61		SM-4A [stimulated monkey] [18 autoradiographs], 1973
62		SR-1 through SR-5 [visual experiment]; SSR-1 through SSR-4 [sciatic nerve stimuli]; AUD-test and 2 through AUD-4 [auditory experiment] [24 autoradiographs], 1973-1974
62		ARF-1 through ARF-16 [CBF antiyprene] [18 autoradiographs], 1974
62		Monkey and rat intestines [1 radiograph], 1974
62		SM-3A [stimulated rhesus monkey] [19 autoradiographs], 1974
62		SM-5 [stimulated rhesus monkey] [16 autoradiographs], 1974
62		SM-6 [stimulated rhesus monkey] -- experiment documentation, 1974
62		SM-6 [stimulated rhesus monkey] [28 autoradiographs], 1974
62		SM-7 [stimulated monkey] [5 autoradiographs], 1974
62		SM-8A [stimulated rhesus monkey] [13 autoradiographs], 1974
62		SM-9A [stimulated rhesus monkey] [11 autoradiographs], 1974
62		SM-10 [stimulated monkey] [21 autoradiographs], 1974
62		SM-11 [stimulated rhesus monkey] [13 autoradiographs], 1974
62		SM-12 [stimulated rhesus monkey] [13 autoradiographs], 1974
62		SM-13 [stimulated rhesus monkey] [26 autoradiographs], 1974
62		AR-1 through AR-13 [anesthesia studies] [16 autoradiographs], 1974-1975
63		CR-1-5, 101-105; CB-4-7, 9; CRF-201; C02 5 percent [22 autoradiographs], 1974-1976
63		CRF-2-15, 101-105, 111-115 [33 autoradiographs], 1974-1975
63		FD1 [1 radiograph], 1975
63		GBL-12 through GBL-15 [4 autoradiographs], 1975
63		GL1 Cat [8 autoradiographs], 1975
63		MTZ-2 [2 autoradiographs], 1975
63		PEN-1 through PEN-3 [penicillin seizure studies] [3 autoradiographs], 1975
63		Pen Cat-1 [8 autoradiographs], 1975
63		SLC-1 through SLC-2 [15 autoradiographs], 1975
63		SM-14 [stimulated rhesus monkey] [16 autoradiographs], 1975
63		SM-15 [stimulated rhesus monkey] [22 autoradiographs], 1975
63		SM-16 [stimulated rhesus monkey] [32 autoradiographs], 1975
63		SM-17 [stimulated rhesus monkey] [29 autoradiographs], 1975
63		SM-18 [stimulated rhesus monkey] [23 autoradiographs], 1975
64		SM-19 [stimulated rhesus monkey] [19 autoradiographs], 1975
64		SM-20 [stimulated rhesus monkey] [16 autoradiographs], 1975
64		SM-21 [stimulated rhesus monkey] [20 autoradiographs], 1975
64		SM-22 [stimulated rhesus monkey] [22 autoradiographs], 1975
64		WB-6-10, 13, 19 [13 autoradiographs], 1975
64		KSA-101-102, 104-111; KSH-1 through KSH-10; KSM-101 through KSM-102 [Kety-Schmitt assay] [16 autoradiographs], 1975-1976
64		LSD-DG-1-4, 1-13, 101-105, 151-153, 201-205, 301-305, 301-303, 401-407, 501-504, 601-603, 701 [57 autoradiographs], 1975-1976
64		MR, MA, MN, NAL, OIL -- experiment documentation, 1975-1976
64		MR-1-8, 101-104, 202-204; MA-2 through MA-6; MN-1 through MN-6; NAL-1 through NAL-6; OIL-1 through OIL-2 [morphine active chronic -- naloxone] [45 autoradiographs], 1975-1976
65		REM Cat-1 through REM Cat-3 [23 autoradiographs], 1975-1976
65		End-1 through End-12 [endorphins] [12 autoradiographs], 1976
65		End NC-1 through End NC-6 [6 autoradiographs], 1976
65		IOD Cat-1 through IOD Cat-2 [7 autoradiographs], 1976
65		IOD Cat-1 through IOD Cat-2 [8 autoradiographs], 1976
65		IOD Cat-3 [9 autoradiographs], 1976
65		IOD Cat-4 [6 autoradiographs], 1976
65		IOD Cat-5 [9 autoradiographs], 1976
65		IOD Cat-6 [8 autoradiographs], 1976
65		IOD Cat-7 [7 autoradiographs], 1976
65		IOD gamma-1 through IOD gamma-13; cold brain [15 autoradiographs], 1976
65		IODO-1 through IODO-6; Antipyrine-1 through Antipyrine-6 and trial [13 autoradiographs], 1976
65		NBM-1 [new born monkey] [18 autoradiographs], 1976
65		NBM-2 [new born monkey] [16 autoradiographs], 1976
65		NBM-3 [new born monkey] [15 autoradiographs], 1976
65		NBM-4 [new born monkey] [15 autoradiographs], 1976
65		NBM-5 [new born monkey] [16 autoradiographs], 1976
65		NBM-6 [new born monkey] [17 autoradiographs], 1976
65		NBM-7 [new born monkey] [17 autoradiographs], 1976
65		NBM-8 [new born monkey] [17 autoradiographs], 1976
65		NBM-101 [new born monkey] [22 autoradiographs], 1976
66		Piridine#1 [1 radiograph], 1976
66		REM Cat-4 and SLC-6 [11 autoradiographs], 1976
66		REM Cat-5 -- experiment documentation, 1976
66		REM Cat-5 [7 autoradiographs], 1976
66		SM-23 [stimulated rhesus monkey] [18 autoradiographs], 1976
66		SM-24 [stimulated rhesus monkey] -- experiment documentation, 1976
66		SM-24 [stimulated rhesus monkey] [14 autoradiographs], 1976
66		SM-25 [stimulated rhesus monkey] [15 autoradiographs], 1976
66		SM-27 [stimulated rhesus monkey] [21 autoradiographs], 1976
66		SM-28 [stimulated rhesus monkey] [31 autoradiographs], 1976
66		SM-29 [stimulated monkey] [24 autoradiographs], 1976
66		SM-30 [stimulated monkey] [23 autoradiographs], 1976
66		ADR-1 through ADR-12; PRP-0 through PRP-13; PH-0 through PH-14; L-ALP-3 through L-ALP-6; CSPE-1 through CSPE-4; PPE-1 through PPE-6; PRP and PH-1; SOT-1 through SOT-3; D-PRP-0 through D-PRP-4; L-PRP-0 through L-PRP-4 [74 autoradiographs], 1976-1977
66		D-AMP-1-8, 101, 103-109; L-AMP-1-7, 101-105; HLNC-1 through HLNC-15 [42 autoradiographs], 1976-1977
67		CS-1 through CS-27; D-1; CSO-2; C-DEX-1; DEX-1 through DEX-4 [control saline] [43 autoradiographs], 1976-1979
67		CS, YOH, DEX, PH, D-AMP, PX -- experiment documentation, 1976-1979
67		CS-23; YOH-1 and 14; DEX-5; PH-2 and 6; D-AMP-102; PX-12, 14, 16, 21 [20 autoradiographs], 1976-1979
67		DG-136, 148, 167-168, 172, 174-181, 187-189; Tail-1 through Tail-6 [41 autoradiographs], 1976-1978
67		DG-124-135, 137-138, 142-145, 149-151, 154-158, 163, 165-166, 171, 173; PH9; FRD-3 [38 autoradiographs], 1976-1978
67		AR-1 through AR-6, AR-8 [aged rats] [10 autoradiographs], 1977
67		Cat-101 through Cat-105 [39 autoradiographs], 1977
67		CBS-4 through CBS-6; CS-1 through CS-2 [8 autoradiographs], 1977
67		DGX; DG [58 autoradiographs], 1977
67		Fetal sheep -- experiment documentation, 1977
67		Fetal sheep-1 through 6, and 8-13 [14 autoradiographs], 1977
68		Fetal sheep-3 -- experiment documentation, 1977
68		Fetal sheep-3 [10 autoradiographs], 1977
68		Free moving-1 [free moving vs. N20 bag rats] [1 radiograph], 1977
68		Free moving-1 through Free moving-9; N20 bag-1 through N20 bag-8 [free moving vs. N20 bag rats] [26 autoradiographs], 1977
68		HIG-1 through HIG-5 [normal control] [10 autoradiographs], 1977
68		IOD Cat-8 [7 autoradiographs], 1977
68		NC-1 through NC-6 [6 autoradiographs], 1977
68		NO-1 through NO-6; NOF-1 through NOF-6; Free moving-1 through Free moving-8 [nitrous oxide/free moving] [20 autoradiographs], 1977
68		One ear rat [3 autoradiographs], 1977
68		RBAA-18(test) [1 radiograph], 1977
68		RTAA1 [2 autoradiographs], 1977
68		SCD-KCL-1 through SCD-KCL-17; SCD-5; SCD-0-1, 2, 3, and 5; SCD-NACL-1; SCD-OK-1 through SCD-OK-15; SCD-OKF-1; SCD-F-1 through SCD-F-8 [spreading cortical depression] [50 autoradiographs], 1977
68		SM-31 [stimulated rhesus monkey] [20 autoradiographs], 1977
68		SM-32 [stimulated monkey] [22 autoradiographs], 1977
68		SM-33 [stimulated rhesus monkey] [16autoradiographs], 1977
68		SSM-1 [18 autoradiographs], 1977
68		SSM-2 [26 autoradiographs], 1977
68		SSM-3 [17 autoradiographs], 1977
68		SSM-4 [18 autoradiographs], 1977
69		ABS-1 through ABS-4; 1856-5 through 1856-8; Toxin-1, 12-14 [24 autoradiographs], 1977-1978
69		ARC-1 through ARC-8 -- experiment documentation, 1977-1978
69		ARC-1 through ARC-8 [14 autoradiographs], 1977-1978
69		GS-1 through GS-17 [gastric secretion] [51 autoradiographs], 1977-1978
69		Harvard rat-1-7, 10, 13-17 [36 autoradiographs], 1977, 1979
69		MIK-1, 2, 5, 9-10; MAK-1, 6, 8-13; B-1, 2, 5, 7-9, 11-15 [44 autoradiographs], 1977-1978
69		SCD-20-1 and SCD-20-2; SCD-40-1 and SCD-40-2; SCD-M-1 through SCD-M-3; SCD-80-1; SCD-150-1 [spreading cortical depression] [22 autoradiographs], 1977-1978
69		DEX-1 through DEX-5; DEXT-PX-1 through DEXT-PK-5; Ph-8 [dextran] [31 autoradiographs], 1977-1979
70		A-9 [2 autoradiographs], 1978
70		ACL-1, 3, and 4; BCL-1 through BCL-4 [albino/pigmented rats continuous intense light exposure] [14 autoradiographs], 1978
70		ADVS-1 through ADVS-4; BDVS-1 through BDVS-4 [16 autoradiographs], 1978
70		AE, BE, ABE, BBE [albino/pigmented enucleation studies] -- experiment documentation, 1978
70		AE-1 through AE-5; BE-1 through BE-5; ABE-1; BBE-1 [40 autoradiographs], 1978
70		Airbag-1 through Airbag-9 [air bag #8 normal control] [19 autoradiographs], 1978
70		AVS, BVS, ADR, MAK-TI, MAK-II -- experiment documentation, 1978
70		AVS-0-1 through AVS-0-4, AVS-0-11 through AVS-0-14; BVS-0-1 through BVS-0-7; ADR-1 and ADR-11; MAK-TI-1 through MAK-TI-2; MAK-II-2 [45 autoradiographs], 1978
70		Cat Cord 1 (spinal cord and brain) [17 autoradiographs], 1978
70		CL-CT-1 [3 autoradiographs], 1978
70		Dee [36 autoradiographs], 1978
70		DG-182-186, 190-196, 198-199 [28 autoradiographs], 1978
71		Fetal sheep 221 [21 autoradiographs], 1978
71		Fetal sheep 228 -- experiment documentation, 1978
71		Fetal sheep 228 [15 autoradiographs], 1978
71		Fetal sheep 244 -- experiment documentation, 1978
71		Fetal sheep 244 [16 autoradiographs], 1978
71		GRC-10B [1 radiograph], 1978
71		GS-19-20, 22-33, 36-45 [gastric secretion] [75 autoradiographs], 1978
71		GS-27and GS-38 [2 autoradiographs], 1978
71		Lamb-1 through Lamb-2 [11 autoradiographs], 1978
71		MG-64 [2 autoradiographs], 1978
71		MSG-1 through MSG-7 [21 autoradiographs], 1978
72		MSG-6 [2 autoradiographs], 1978
72		NaCl-1 through NaCl-9; MSB-2, 4, 5; DG-170 [saline group] [34 autoradiographs], 1978
72		Phosphate-1 through Phosphate-32 [33 autoradiographs], 1978
72		Rocky-1 through Rocky-32 [stimulated monkey] [38 autoradiographs], 1978
72		SCD-80-1 through SCD-80-4; SCD-80-6 through SCD-80-10 [spreading cortical depression] [18 autoradiographs], 1978
72		SCD-V-1-0; SCD-V-1 through SCD-V-10; SCD-90-11; SCD-OK-21 through SCD-OK-22 [spreading cortical depression] [28 autoradiographs], 1978
72		Space Cat-A and Space Cat-B [2 autoradiographs], 1978
72		Stand VS-S-1 and Stand VS-3 [3 autoradiographs], 1978
72		Windy [33 autoradiographs], 1978
72		YOH-3-7, 10-13 [27 autoradiographs], 1978
72		Zieg-C [2 autoradiographs], 1978
72		ANL-1 through ANL-4; BNL-1 through BNL-4; AVS-1-4, 21-24, 31-34, 41-44; BVS-1-4, 21-24, 31-34, 41-44, 51-54 [85 autoradiographs], 1978-1979
73		APO-7, 13 -- experiment documentation, 1978-1979
73		APO-7, 13 [31 autoradiographs], 1978-1979
73		APO-18-1 through APO-18-7; APO-C through APO-3C -- experiment documentation, 1978-1979
73		APO-18-1 through APO-18-7; APO-C through APO-3C [38 autoradiographs], 1978-1979
73		DG-200-205, 207-217; CK-1 through CK-2 [43 autoradiographs], 1978-1979
73		SCG -- experiment documentation, 1978-1979
73		BDSCG-1 and BDSCG-2; BSDSCG-1 and BSDSCG-2; BD2SCG-1 and BD2SCG-2; BD3SCG-1 and BD3SCG-2 [8 autoradiographs], 1978-1979
73		IHG-1 through IHG-8 [17 autoradiographs], 1978-1979
73		LIDO-1 through LIDO-13 [Lidocaine] [31 autoradiographs], 1978-1979
74		LIDO-1, 2, 5-13 [Lidocaine] [24 autoradiographs], 1978-1979
74		PX-0-9, 13-20, 22 [phenoxybenzomine] [52 autoradiographs], 1978-1979
74		SHR-4 [1 autoradiograph], 1978-1979
74		YOH-14 through YOH-29 [47 autoradiographs], 1978-1979
74		APO-4-1 through APO-4-12 -- experiment documentation, 1979
74		APO-4-1 through APO-4-12 [33 autoradiographs], 1979
74		APO-28-1 through APO-28-6 -- experiment documentation, 1979
74		APO-28-1 through APO-28-6 [27 autoradiographs], 1979
74		Cat- experiment documentation [2 folders], 1979
75		Cold brain w/ hot holes -- experiment documentation, 1979
75		Cold brain w/ hot holes -1 and 2 [7 autoradiographs], 1979
75		DG-206, 216-217 [16 autoradiographs], 1979
75		DX-1 [glycerol perfused brain] [1 radiograph], 1979
75		GC-1 [2 autoradiographs], 1979
75		Gee [32 autoradiographs], 1979
75		Harvard sleep rat-1 through Harvard sleep rat-4 [16 autoradiographs], 1979
75		HY, HYP, HY-CONT, HYR -- experiment documentation [hypoxia (pigmented rats)], 1979
75		HY-1-6, 20-21, 601; HYP-1 through HYP-4; HY-7-9, 10-12, 21-26; HY-CONT-2-4, 6, 7; HYR-1 through HYR-2 [95 autoradiographs], 1979
76		HY-7 [1 radiograph], 1979
76		HY-cont-5 -- experiment documentation, 1979
76		HY-cont-5 [3 autoradiographs], 1979
76		KK-1 [1 radiograph], 1979
76		Milt-1 through Milt-32 [32 autoradiographs], 1979
76		PCP-2 [2 autoradiographs], 1979
76		Reza [25 autoradiographs], 1979
76		Sugar-1 through Sugar-29 [30 autoradiographs], 1979
76		TOE-1 [toe stimulation] [6 autoradiographs], 1979
76		Acid -- experiment documentation (23, 32), 1979-1980
76		Acid-1, 6-9, 16, 20, 22-26, 32-41; NOR-4 through NOR-5; Heart-10 through Heart-12 and Heart-18; CHO-13 [68 autoradiographs], 1979-1980
76		Landau [24 autoradiographs], 1979-1980
76		SCG -- 1A5 through 4A5; 2A10 through 4A10; CA15; 1A15, 3A15, 4A15; 1A20 through 4A20 [15 autoradiographs], 1979-1980
77		Amanda -- experiment documentation, 1980
77		Amanda; Amanda eyes; Amanda spinal cord [31autoradiographs], 1980
77		Atlas-1 [3 autoradiographs], 1980
77		BSL-1 and BSL-3 [2 autoradiographs], 1980
77		Cat 201 [8 autoradiographs], 1980
77		Cat 202 [10 autoradiographs], 1980
77		Cat 203 [10 autoradiographs], 1980
77		CSN-12 [17 autoradiographs], 1980
77		Dreamless -- experiment documentation (3-6, 19-24), 1980
77		Dreamless -test, 2-29 [29 autoradiographs], 1980
77		Marley [37 autoradiographs], 1980
77		N2O-2 and N2O-4 [2 autoradiographs], 1980
77		OLF -- experiment documentation, 1980
77		OLF-1 through OLF-2 [4 autoradiographs], 1980
77		Posh -- experiment documentation (7-10, 13-15, 19-24), 1980
77		Posh -test, 1-10, 13-26 [26 autoradiographs], 1980
77		PRT-2 through PRT-4 [12 autoradiographs], 1980
78		Retina-1 through Retina-3 -- experiment documentation, 1980
78		Retina-1 through Retina-3 [11 autoradiographs], 1980
78		Valium diazepam -- experiment documentation [i.e. VALC, VALL, VALIUM, VAM, VALM], 1980
78		VALC-1 through VALC-8; VALL-1 through VALL-6; VALIUM-1, 2, 4 through 6; VAM-1 through VAM-6; VALM-3 and VALM-7 [70 autoradiographs], 1980
78		SCG-63, 65-66, 74, 76, 78, 80, 83, 101, 131; and CONT-1 and 2 [34 autoradiographs], 1980, 1983
78		HBC, LHB -- experiment documentation, 1980-1981
78		HBC-1 through HBC-4; LHB-1, 3-8 [unilateral lesion of habenula] [31 autoradiographs], 1980-1981
78		HG-1-3, 5-6, 8-9, 12-15; LCGU-73; HPYGL-3; Hyper-74 [48 autoradiographs], 1980-1982
78		HG; HG-SCG; HG-Pit; HG-Ganglia; HGC; CO; Hyper -- experiment documentation, 1980-1983
78		HG-3-10, 12-15; HG-SCG-27-32; HG-Pit-1-33; HG-ganglia-2, 3, 5, 6, 9-10, 12-15, 21-26; HGC-1-3; CO-1-2; Hyper-4-5 [73 autoradiographs], 1980-1983
78		MRC, MRH, MRM, MC, Morph, M10 -- experiment documentation, 1980-1981
79		MRC-1 through MRC-2; MRH-1 through MRH-9; MRM-1 through MRM-6; MC-6; Morph cont-1 through Morph cont-5; Morph-1 through Morph-8; M10-1 through M10-6 [morphine low dose saline] [96 autoradiographs], 1980-1981
79		Rat 85c and 87b [5 autoradiographs], 1980-1981
79		Rat 812b through Rat 829 [26 autoradiographs], 1980-1981
79		Sleep control -- spinal cord-(various) [12 autoradiographs], 1980-1981
79		AC-1 through AC-5 [17 autoradiographs], 1981
79		AL-1 through AL-6 [23 autoradiographs], 1981
79		Blue; Bube-test [46 autoradiographs], 1981
79		Cat 729 through Cat 730 [18 autoradiographs], 1981
80		Chili-test, 1-31, 33-39 [39 autoradiographs], 1981
80		Fen Con-1-2, 4-5 -- experiment documentation, 1981
80		Fen Con-1-2, 4-5 [18 autoradiographs], 1981
81		Fetal sheep 178 -- experiment documentation, 1981
81		Fetal sheep 178 -- test, 1-16 [25 autoradiographs], 1981
81		Fetal sheep 181 -- experiment documentation, 1981
81		Fetal sheep 181 -test, 1-14 [18 autoradiographs], 1981
81		Fredrik, Hans, Inge [20 autoradiographs], 1981
81		Isabella-1 through Isabella-8 (plus others) [19 autoradiographs], 1981
81		Ketacat [14 autoradiographs], 1981
81		RC-1-3, 5-15, 17-23; RC heart-6-15, 17-21 [36 autoradiographs], 1981
81		RC-500 through RC-514 [32 autoradiographs], 1981
81		Toast-test, 1-27, 28-42 [sleep lps before fixation] [44 autoradiographs], 1981
82		A -- experiment documentation, 1981-1983
82		A-101-111, 113-116, 118-122, 125-126s, 132-134, 136-137 [75 autoradiographs], 1981-1983
82		AGE M-1 through AGE-M-5; AGE MC-1 through AGE-MC-6 -- experiment documentation, 1981-1982
82		AGE M-1 through AGE-M-5; AGE MC-1 through AGE-MC-6 [36 autoradiographs], 1981-1982
82		ASP; ASP Fixed [66 autoradiographs], 1981-1982
82		Fetal sheep 163 -- experiment documentation, 1981-1982
82		Fetal sheep 163-1 through Fetal sheep 163-14 [14 autoradiographs], 1981-1982
82		Fetal sheep 163 -- experiment documentation, 1981-1982
82		Fetal sheep 163-test, 5-12, 14 [13 autoradiographs], 1981-1982
83		SCG [sham operation under urethane] -- experiment documentation, 1981-1983
83		SCG-37, 75-77, 79, 84-86, 102-110, 113-117 [sham operation under urethane] [65 autoradiographs], 1981-1983
83		AN-1 through AN-12 -- experiment documentation, 1982
83		AN-1 through AN-12 [36 autoradiographs], 1982
83		AP-1 through AP-33 [38 autoradiographs], 1982
83		AP-ganglion-16-17, 24-26; AP-pituitary-1-4, 6-7, 9, 11-12, 16-17, 22-26, 28-29, 31 [17 autoradiographs], 1982
83		Chicle 1-10, 14, 16-17, 19, 22, 25-29, 32, 34-35, 37-38, 40, 46, 49-57, 59-62 [41 autoradiographs], 1982
83		Chicle 11-13, 15, 18, 20-21, 23-24, 30-31, 33, 36, 39, 41-43, 45, 47, 58 [20 autoradiographs], 1982
84		DG-81-1 -- experiment documentation, 1982
84		DG-81-1 [34 autoradiographs], 1982
84		DG-81-2 [31 autoradiographs], 1982
84		DG-81-3 -- experiment documentation, 1982
84		DG-81-3 -- [28 autoradiographs], 1982
84		Egad -- experiment documentation, 1982
84		Egad [15 autoradiographs], 1982
84		Egad-1-3, 5-7, 16, 22-24, 26-27 [13 autoradiographs], 1982
84		Fetal sheep 161 -- experiment documentation, 1982
84		Fetal sheep 161 [28 autoradiographs], 1982
84		Fetus 164 -- experiment documentation, 1982
84		Fetus 164 [9 autoradiographs], 1982
84		Fetal sheep 169 -- experiment documentation, 1982
85		Fetal sheep 169 [25 autoradiographs], 1982
85		Helix 1-8, 10-14, 17-30 [33 autoradiographs], 1982
85		Helix 9, 14-16, 19, 21-22, 24-25, 27-30, 38-39, 42-43, 45, 55 [18 autoradiographs], 1982
85		Helix 20, 32, 44, 48 [4 autoradiographs], 1982
85		Helix 29, 31-37, 40, 44, 46-54, 56-57; Leana test [22 autoradiographs], 1988
85		Hokfelt [no numbering] [18 autoradiographs], 1982
85		LE-11 and LE-13 [6 autoradiographs], 1982
85		PC-1 through PC-14 [43 autoradiographs], 1982
85		RC-401 through RC-416 -experiment documentation, 1982
85		RC-401 through RC-416 [22 autoradiographs], 1982
85		Rony-test, 1-29, 31-35 [36 autoradiographs], 1982
86		Toast [27 autoradiographs], 1982
86		AMP-1 through AMP-13; LP-4 [40 autoradiographs], 1982-1984
86		BHLB and HBC -- experiment documentation, 1982-1983
86		BHLB-1 through BHLB-13; HBC-5 through HBC-9 [bilateral lesion of leiteral habenula] [54 autoradiographs], 1982-1983
86		DI-4 and DI-18 [4 autoradiographs], 1982-1983
86		LHRH-1 through LHRH-26 [84 autoradiographs], 1982-1983
86		LHRH Pituitary -- experiment documentation, 1982-1983
86		LHRH pit-1 through LHRH pit-26 [11 autoradiographs], 1982-1983
87		CAF-1 through CAF-23; JOB-1 [caffeine 1] [88 autoradiographs], 1983
87		CAF pit-1-2, 5-7, 9-20; CAF ganglion-1-2, 5-7, 9-20; CAF pit and ganglion-4, 8, 21-23 [caffeine 1] [19 autoradiographs], 1983
87		CCK-1-7, 9, 21-26 -- experiment documentation, 1983
87		CCK-1-7, 9, 21-26 [41 autoradiographs], 1983
87		CCK-pit-1-7, 9-11, 21-24 [8 autoradiographs], 1983
87		HG-21-23, 25-33 [36 autoradiographs], 1983
87		ISMA 8-45, 47-59 [63 autoradiographs], 1983
88		Kazoo [41 autoradiographs], 1983
88		Kazoo -- experiment documentation, 1983
88		Kazoo [17 autoradiographs], 1983
88		Percy 1-11, 15, 18, 20, 22-29, 33-34, 36-38, 40, 42-43, 45, 47-55, 57-61 [47 autoradiographs], 1983
88		Percy 12-14, 16-17, 19, 21, 30-32, 35, 39, 41, 44, 46, 56 [16 autoradiographs], 1983
88		Pez 1-8, 10-14, 17, 22, 24, 28, 30, 32, 35, 38, 40 43-44, 47-55, 57-62 [40 autoradiographs], 1983
88		Pez 9, 15-16, 18-21, 23, 25-27, 29, 31, 33-34, 36-37, 39, 41-42, 45-46, 56 [23 autoradiographs], 1983
88		Piggie-1 through Piggie-2 [6 autoradiographs], 1983
88		RD, RD-PIT, RAD, RCA -- experiment documentation, 1983
88		RD-1, 4, 7, 10, 12, 13; RD-PIT-1, 2, 4, 5, 9, 10, 13; RAD-1, 2, 8, 10, 19, 20; RCA-1 through RCA-3 [radiation] [45 autoradiographs], 1983
89		RD-5, 7, and 9 [radiation] [9 autoradiographs], 1983
89		Sandro-1-3, 5-7, 9-12, 15-19, 101-109, 112-117, 301-302, 304-316 [57 autoradiographs], 1983
89		Sheep fetus 126 [11 autoradiographs], 1983
89		SOL BERL-test 1 and 2 [5 autoradiographs], 1983
89		Sparky-test, 1-36 [37 autoradiographs], 1983
89		Taro-101-103, 105-108, 112-119, 201-216 [32 autoradiographs], 1983
89		SCG-119 and SCG-120, with draft of Alterations of local cerebral glucose utilization during chronic dehydration in rats [2 autoradiographs], 1983-1984
89		Stick-test, 14; ISMA-46 [3 autoradiographs], 1983, 1988
90		CBF Isch-1, 3-7; BF-1 through BF-3 [47 autoradiographs], 1984
90		HPG-1 through HPG-11 [49 autoradiographs], 1984
90		RK-450 [15 autoradiographs], 1984
90		VAG-1 through VAG-2 [6 autoradiographs], 1984
90		Woody 10, 34-36, 38, 41-43, 46-47, 49, 51, 53, 55-60, 62-64, 67, 78 [24 autoradiographs], 1984
90		DGSF-101 through DGSF-104; MGSF-1 through MGSF-3; MEC-1 through MEC-2; Mind-1 -- experiment documentation, 1984-1985
91		DGSF-101 through DGSF-104; MGSF-1 through MGSF-3; MEC-1 through MEC-2; Mind-1 [24 autoradiographs], 1984-1985
91		EP, DEP, I-EP, D, IND, PBS -- experiment documentation, 1984-1985
91		EP-1 through EP-5, EP-C1; DEP-1-4, 6; I-EP-1 through I-EP-5; D-1 through D-5; IND-1 through IND-5; PBS-5, C2, C3 [100 autoradiographs], 1984-1985
91		MBF-1-2, 4-10, 12, 14, 16, 17-21 [mouse blood flow] [39 autoradiographs], 1984-1985
91		Woody 1-9, 11-33, 37, 39-40, 44-45, 48, 50, 52, 54, 61, 65-66, 68-77, 79-87 [63 autoradiographs], 1984-1985
92		AN-13-15, 17-23 -- experiment documentation, 1985
92		AN-13-15, 17-23 [30 autoradiographs], 1985
92		EC-1-4, 6-7; G6 PASE [22 autoradiographs], 1985
92		G6 PASE-1-3, 5-58; G6 PASE-P1, 2, 4, 6, 7 [70 autoradiographs], 1985
92		H-6; HM [6 autoradiographs], 1985
92		Leonard -- DG study of 3-month infant with laser lesion of retina -- documentation, 1985
92		Papez-9 through Papez-10 [7 autoradiographs], 1985
92		Leonard [111 autoradiographs], 1985
92		MDGC-1 through MDGC-5; MDGG-1, 3-5; MDGO-2 through MDGO-5 -- experiment documentation, 1985
92		MDGC-1 through MDGC-5; MDGG-1, 3-5; MDGO-2 through MDGO-5 [38 autoradiographs], 1985
92		MG, MG INS -- experiment documentation, 1985
93		MG-001 through MG-002; MG INS-I through MG INS-II [18 autoradiographs], 1985
93		Pablo [63 autoradiographs], 1985
93		PTX-1 through PTX-9 [25 autoradiographs], 1985
93		WDG-1 through WDG-4 [13 autoradiographs], 1985
93		WV-1-4, 14 [9 autoradiographs], 1985-1986
93		IFNA-1 through IFNA-2; IFNC-1 [interferon] [11 autoradiographs], 1986
93		PCP-1, 2, 4, 8-10, 14, 23, 26 [25 autoradiographs], 1986
93		PCP-3, 7, 12, 13 [12 autoradiographs], 1986
93		PCP-6 and PCP-11 [6 autoradiographs], 1986
94		PCP-5, 14-25, 27, 28 [44 autoradiographs], 1986
94		PCP-5 -- experiment documentation, 1986
94		PT-2-3, 6-18, 20-29, 31-44 [pulse experiments] [39 autoradiographs], 1986
94		SA-2-6, 9-12, 14-19 [50 autoradiographs], 1986
94		SA-20-23, 25-39 [65 autoradiographs], 1986
95		SA-40-46, 48-54, 56-59 [56 autoradiographs], 1986
95		SA-60-65, 67-79, 81-83 [72 autoradiographs], 1986
95		Sneezy [18 autoradiographs], 1986
95		WV-10 through WV-13; WH-2 [10 autoradiographs], 1986
95		CJ-1 through CJ-4; Jose-1 through Jose-4 [24 autoradiographs], 1986-1987